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ABSTRACT

THE EFFECT OF ASTYM® TREATMENT ON MUSCLE PERFORMANCE

By
Benjamin R. Kivlan
December 2014

Dissertation Supervised by RobRoy L. Martin PhD, PT
Purpose: Astym® treatment is a manual therapy intervention performed to stimulate
tissue regeneration and treat pain, limited mobility, and muscle weakness for patients
with musculoskeletal pathology. The purpose of this study was to determine if Astym®
treatment administered to the lower extremity of individuals with lower extremity
musculoskeletal injuries would result in an immediate change of maximal force output
during a unilateral isometric squat test.

Subjects: Forty-five subjects (14males; 31females) aged between 18-65 years
participated in this study. Criteria for inclusion in the study were: a lower extremity
musculoskeletal injury with a resulting deficit of at least 10% in isometric squat strength
of the involved limb; and a lower extremity functional score of 40-70 out of 80 points.
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Materials/Methods: Subjects were randomized into 3 treatment groups (15 subjects per
group): 1) Control – received no treatment 2) Placebo – received a sham Astym®
treatment 3) Astym® Treatment – received Astym® treatment to the lower extremity.
Subjects were blinded to whether they received the Astym® treatment or placebo
treatment intervention. After a 5-minute warm-up on a lower body ergometer the
subjects were familiarized to the operations of a computerized leg press machine that
measured the maximum force output (Newtons) during a unilateral isometric squat test.
A baseline measure of maximal force output (pre-test) was determined by the average of
3 trials with a 30 second rest period between the trials. The subjects then received the
designated treatment intervention. Immediately following the treatment intervention the
subjects were retested (post-test) using identical testing procedures by an investigator
blinded to the treatment intervention received by the subject. The percent change of
maximal force output from pre-test to post-test measures was compared using a one-way
analysis of variance with alpha set at 0.05. A Tukey’s post-hoc analysis determined
statistical differences between the groups.

Results: A significant effect was observed on the percent change of maximal force
output at the p<0.05 level for the Astym®, placebo, and control treatment interventions
[F(2,42) = 7.91, p = 0.001]. Tukey’s post hoc analysis demonstrated that the percent
change of maximal force output was significantly greater in the Astym® group
(15+18%change) compared to the placebo (-6+11%change) and control(-1+17%change)
groups. No significant difference (p=0.68) was noted between the control and placebo
groups.

v

Conclusions: Astym® treatment to the involved lower extremity increases maximum
force output during an isometric squat test immediately following treatment. A placebo
treatment and a control treatment did not change maximal force output of the lower
extremity.

Clinical Relevance: The results of this study suggest that Astym® treatment can be used
as a treatment intervention for the immediate improvement of muscle performance for
patients presenting with a muscle strength deficit caused by a musculoskeletal injury to
the lower extremity. This may expand the use of Astym® treatment for patients with
muscular weakness in an effort to improve functional activities or athletic performance.
The longevity of the effect of Astym® treatment on muscle performance, however,
remains unknown.
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Chapter 1
Introduction
1.1Background
Physical therapists treat individuals with various types of injuries to the
musculoskeletal system. This includes soft-tissue injuries affecting muscles, tendons,
fascia, joint capsules, and ligaments. To treat soft-tissue injuries, physical therapists may
employ various types of therapeutic interventions such as electrical stimulation,
ultrasound, infrared laser, cryotherapy, strengthening exercises, and soft-tissue
mobilization techniques. However, injuries to soft-tissue structures can be challenging to
resolve and resilient to traditional therapeutic interventions.1 New soft-tissue
mobilization techniques have evolved that utilize specialized instruments, tools, or
devices to facilitate healing and address the impairments associated with soft-tissue
injuries.2 Astym® treatment is an innovative instrument assisted soft-tissue mobilization
technique that has been shown to stimulate soft-tissue regeneration and address common
impairments such as pain, limitations in mobility, and muscle weakness that may
accompany soft-tissue injury.1,3-11
Astym® treatment is a manual therapy technique applied with the use of
specialized handheld instruments (Figure 1).1 The instruments are guided across the
surface of an individual’s skin, parallel to the fiber orientation of the underlying softtissue structures.1 These underlying ligamentous, deep fascial, muscular, and tendinous
1

tissues present with a different texture than the skin and superficial fascia. This
difference in texture can be felt through the Astym® instruments by the therapist.12 The
therapist will judge the appropriate amount of pressure to apply with the instruments
based on feeling the distinct texture of the ligamentous, deep fascial, muscular, and
tendinous tissues with the Astym instruments.12 Individuals that are lean will require
less pressure through the instruments to contact the target tissues.12 Individuals that have
greater adipose in the superficial fascia will require greater pressure applied through the
instruments in order to feel the change of the tissue textures necessary to mechanically
stimulate underlying ligamentous, deep fascial, muscular, and tendinous tissues.12
Mechanical stimulation of the soft-tissue structures initiates the body’s innate
mechanisms of healing 13,14 and may reduce pain while improving mobility and muscle
strength.1,3-11 Astym® treatment differs from other methods of soft-tissue mobilization
techniques in that the treatment is administered to an entire limb segment with a specific,
sequential protocol. Thus a typical session of Astym® treatment incorporates treatment to
soft-tissue structures proximal and distal to the focal area of injury or pathology. Each
Astym® treatment session lasts approximately 15 minutes and is accompanied by
stretching and strengthening exercises determined by the physical therapist.12
The indications for Astym® treatment are pain, limited mobility, and impaired
muscle performance as the result of common musculoskeletal pathologies. 5,11 Astym®
treatment is believed to alter the recipient’s perception of pain through mechanical
stimulation of soft tissues. In cases of chronic pain caused by soft-tissue dysfunction,
Astym® treatment is thought to help the body absorb dysfunctional soft tissue and return
it to a healthy, pain-free state.13-15 Several case studies have shown that Astym®
2

treatment can reduce pain caused by common musculoskeletal pathologies including
epicondylosis 5, carpal tunnel syndrome,16 Achilles tendinopathy,8 hamstring
tendinopathy 9 and patellar tendinopathy.17 Astym® treatment has also been successfully
used to improve joint mobility as a result of excessive soft-tissue scarring and
fibrosis.4,6,7,10 In two separate case studies, Henry et al.6,7 demonstrated clinically
significant changes in knee joint range of motion in response to Astym® treatment when
previous conservative and surgical interventions had failed. Astym® treatment was also
used successfully to restore the range of motion to pre-injury levels in 2 separate cases of
patients with ankle joint dysfunction caused by excessive fibrosis.10,11 Davies and
Backopp 4 documented improvements in shoulder mobility in response to Astym®
treatment for a series of patients with limited mobility of the shoulder after mastectomy
surgery.
Anecdotally, therapists have noted Astym® treatment invokes immediate
improvements of muscle performance. Muscle performance is described as the
combination of the strength, power, and endurance of a muscle or group of muscles
necessary to execute a specific task or functional activity.18 Because of the potential
effects of Astym® treatment on muscular performance, athletes have begun receiving
Astym® treatment before training sessions and competitions.19 However, only a few
documented case studies have substantiated the influences of Astym® treatment on
measures of muscle performance.5,9 The impact of Astym® treatment on muscle
performance is an area that needs to be studied in clinically controlled trials.
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Figure 1. Astym® Instruments

Muscular strength is a component of muscle performance. Muscular strength can
be defined as the amount of maximal volitional force produced by the contraction of a
single muscle or a group of muscles.20 Determining the effect of Astym® treatment on
force output may impact how physical therapists implement a treatment program for a
patient presenting with deficits in muscular strength due to common musculoskeletal
pathologies. Lower extremity muscular strength that is measured in the closed kinetic
chain (ex. squat or leg press), is closely associated with the functional abilities of an
individual.21 Unilateral squat strength has been associated with an individual’s ability to
walk and negotiate stairs. 22 A deficit of lower extremity muscular strength has been
shown to be a risk factor associated with falls in an elderly population. 23 In a younger,
active population, squat strength is associated with athletic performance. Comfort et al. 24
demonstrated a significant negative correlation (r= -0.60) of squat strength to timed sprint
speed in athletes and recreationally active, young men. Parchmann & McBride 25 also
demonstrated a relationship in maximal squat strength of collegiate athletes to sprint time
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at 10 meters (r=-0.81) and 20 meters (r=-0.87), respectively. The authors also found a
strong relationship of maximal squat strength to vertical jump height (r=0.87) and agility
test time (r=-0.76). 25 Based on the literature cited above, there is evidence to suggest that
lower extremity muscular strength plays a moderate role in a wide variety of functional
activities.
To date, there is limited evidence to show that patients experience an increase in
muscular performance as a result of Astym® treatment. 5,9 Anecdotally, physical
therapists have noted post-treatment improvements of muscular strength quantified by
handheld dynamometry of the musculotendinous structures treated with the Astym®
instruments. Patients have also reported an immediate improvement of functional
activities that require significant lower extremity muscular strength such as transitioning
from sit to stand or climbing stairs. However, none of these anecdotal findings have been
studied in a randomized clinical trial. This research project will determine if Astym®
treatment improves immediate muscular performance for patients presenting with muscle
weakness due to a musculoskeletal condition. The information gained from this research
project will help determine if Astym® treatment has clinical application to improve
muscle performance. Specifically, it will determine if Astym® treatment has a role in
acutely improving muscular strength in an effort to enhance patient function.

1.2 Operational Definitions
Astym® treatment – An instrument assisted soft-tissue mobilization technique that is
applied using specialized instruments and a specific sequential protocol to stimulate
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tissue regeneration and for the treatment of pain, limited mobility, and muscle weakness
related to common musculoskeletal conditions.

Control group – The group of subjects that were randomized to receive no treatment
intervention.

Placebo group – The group of subjects that were randomized to receive a sham Astym®
treatment that was performed using light pressure with the non-treatment edge of the
Astym® instruments.

Isometric Squat Test - A closed-kinetic chain physical performance test performed
unilaterally on a leg press machine that records the force output produced from a static,
pre-determined position of knee flexion and hip extension.

Therapeutic soft-tissue mobilization - Manual therapy interventions directed to soft-tissue
structures to increase joint range of motion, reduce pain, decrease swelling, increase
flexibility, or improve muscle performance.

Instrument assisted soft-tissue mobilization –Therapeutic soft-tissue mobilization
techniques that utilize specialized tools or instruments for the purpose of treating
common soft-tissue disorders.
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Non-instrumented soft-tissue mobilization –Therapeutic mobilization techniques applied
with the skilled hands of a trained healthcare professional to treat pain, swelling, limited
flexibility, or impaired muscle performance with the goal to improve functional abilities
of a patient.

Muscle performance - The combination of muscle strength, power, and endurance
necessary to execute a specific task or functional activity.

Muscular strength- A component of muscle performance that describes the maximal force
generated by the volitional contraction of a muscle or group of muscles.

Pain - An unpleasant sensory or emotional experience associated with actual or potential
tissue damage.

Neuromuscular Facilitation - An increase of muscle activation through stimulation of the
sensorimotor system.

1.3 Limitations and Assumptions
1. Subjects consistently gave maximal effort during testing.
2. The delivery of Astym® treatment was consistent among subjects.
3. The time from the end of treatment intervention to the beginning of testing was the
same for each subject.
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4. The sample of subjects recruited for this study was representative of a population
of patients attending outpatient physical therapy for a lower extremity
musculoskeletal injury.
5. Any observed differences in muscle strength were a result of whether the patient
had received Astym® treatment, a sham Astym® treatment, or no treatment at all.
6. The results only represented acute changes in muscular strength.
7. The sustainability of any observed effects on muscular strength is unknown.
8. The functional impact of any observed effects of Astym® treatment on muscular
strength remains unknown.

1.4 Delimitations
1. Recruitment of 45 subjects from an outpatient sports medicine and orthopedic
physical therapy clinic.
2. Randomization of subjects into a treatment group.
3. Primary investigator was blinded to the results of the isometric squat tests until all
of the subjects had completed testing.
4. Secondary investigator and the subjects were blinded to the treatment intervention
received.
5. Familiarization of the subjects to the operations of the computerized leg press
machine to account for a learning effect.
6. Established a work:rest ratio to account for muscular fatigue during testing.
7. Astym® treatment was provided by the same provider, with 3 years of clinical
experience administering the technique.

8

1.5 Problem Statement
The purpose of this study was to determine if Astym® treatment administered to
the lower extremity resulted in an acute change of muscular performance as measured by
maximal force output during an isometric squat test among subjects presenting with
weakness associated with a musculoskeletal injury to the lower extremity.

1.6 Independent Variable
The Independent Variable in the present study was the treatment intervention
administered to the subjects. The treatment intervention had three forms:
1. Control – received no treatment (12 minutes of rest)
2. Placebo – received 12 minutes of a sham Astym® treatment to the lower extremity
3. Astym® Treatment – received 12 minutes of Astym® treatment to the lower
extremity

1.7 Dependent Variable
The present study investigated one dependent variable:
1. Percent change (%change) of pre-treatment to post-treatment maximal force
output during an isometric squat test

9

1.8 Hypotheses
1. Astym® treatment will have a significant effect on maximal force output during a
unilateral isometric squat test.
1a. The group of subjects that receive Astym® treatment will produce a
significantly greater percent change in pre-treatment to post-treatment
maximal force output than the subjects that received no treatment (control)
and the subjects that received a sham Astym® treatment (placebo).
1b. The percent change in pre-treatment to post-treatment maximal force
output produced during an isometric squat test for the control and placebo
groups will not be statistically different.

10

CHAPTER 2
Review of Literature
2.1 Introduction
Astym® treatment is a manual therapy technique applied with specialized
instruments by a physical therapist with advanced certification and training in the
technique. There are specific Astym® treatment protocols used in the treatment of
pathologies of the upper extremity, shoulder complex, cervical-thoracic spine, lumbar
spine, hip complex, and lower extremity. Each of the Astym® treatment protocols
addresses the entire kinetic chain that includes treatment to the body regions that are
distal and proximal to the specific area of pathology. For example, Astym® treatment for
patellar tendinopathy includes treatment of the foot, ankle, and leg, as well as the
structures of the hip complex and thigh. Astym® treatment is used to stimulate tissue
regeneration. Astym® treatment may also be indicated to treat pain, limited mobility, and
muscle weakness related to common musculoskeletal conditions. Astym® treatment
provides a mechanical stimulus to soft-tissue structures through the therapist’s
application of the Astym® instruments. There are three Astym® instruments of varying
sizes that are used during each treatment session. The larger instruments are used to
perform longitudinal strokes over the entire length of musculotendinous structures from
the origin to insertion. This is followed by specific strokes using the smaller instruments
over bony prominences where tendons and ligaments commonly attach. A total of 2 sets
11

of strokes in a superior to inferior direction, followed by 2 sets of strokes in an inferior to
superior direction are performed until the entire body region has been treated. The strokes
are applied at a rate of 6-8 inches per second. The amount of pressure applied through
the instruments is enough to feel the unique texture of the ligaments, tendons, deep
fascia, and muscular tissues that are deep to the skin and superficial fascia. Because each
individual possesses a different amount of adipose tissue within the superficial fascia, the
amount of pressure applied through the instruments varies according to each individual’s
body composition. However, contact of the instruments with the muscle, tendon, deep
fascia, and ligamentous tissues as determined by the unique texture that these structures
provide remains consistent regardless of body composition. Therefore, each Astym®
treatment provides a consistent stimulation of the muscle, tendon, deep fascia, and
ligamentous structures despite variability in body composition between individuals.
Once the entire kinetic chain has been treated with all of the appropriate Astym®
instruments in accordance to the regional Astym® protocol, the Astym® treatment is
complete and the patient will perform additional therapeutic exercises and activities as
determined by the physical therapist.
Despite limited evidence, Astym® treatment has shown promise as a therapeutic
intervention to improve muscle performance.5,9 However, the acute effects of Astym®
treatment on muscle performance have yet to be explored in a clinically controlled trial.
The purpose of this literature review is to define the current understanding of the
relationship of Astym® treatment to muscle performance. Emphasis will be placed on
reviewing peer-reviewed literature that explains the known and theorized physiological
mechanisms of Astym® treatment as it pertains to muscle performance. The review will
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further encompass analysis of forms of instrumented and non-instrumented soft-tissue
mobilization techniques employed by physical therapists and the impact of those
interventions on muscle performance. The review will conclude by comparing the
theorized physiological mechanisms and outcomes related to muscle performance to
other forms of instrument assisted and non-instrument assisted soft-tissue mobilization
techniques.

2.2 Influence of Soft-Tissue Mobilization on Muscle Performance
Soft-tissue mobilization techniques facilitate several physiological changes that
have the potential to affect muscle performance. Specifically, soft-tissue treatments are
believed to enhance muscle performance through neuromuscular facilitation (2.2.1),
modulation of pain (2.2.2), mechanosensitivity of the muscle tissue (2.2.3), and increased
blood flow (2.2.4). The physiological mechanisms through which soft-tissue
mobilization techniques, such as Astym® treatment, may act to enhance muscle
performance are explored below.

2.2.1 Neuromuscular Facilitation
Riemann and Lephart 26,27, and Voss et al.

26,27

have theorized that soft tissue-

mobilization techniques may influence muscle performance through activation of the
sensorimotor system.26,27 The sensorimotor system is responsible for resultant changes in
motor or muscle activation that is directly or indirectly attributed to sensory
stimulation.26,27 An increase of muscle activation through stimulation of the sensorimotor
system is referred to as neuromuscular facilitation.27,28 The sensorimotor system receives
13

input from various types of somatosensory receptors found within the skin, fascia,
ligaments, joint capsules, tendons, and muscle tissues. 27,28 The somatosensory receptors
respond to stimuli such as pain, temperature, touch, vibration, and pressure.27,28 When
stimulated the somatosensory receptors send input to the motor processing centers of the
central nervous system.27,28 The pathway from the somatosensory receptors to the central
motor processing centers is referred to as the afferent pathway. The spinal cord,
brainstem, cerebellum, and cerebral cortex collectively integrate afferent signals from the
somatosensory receptors and respond by sending signals via motor neurons to the
appropriate muscle tissue.27 The pathway from the central motor processing centers to
the muscle tissue is known as the efferent pathway. An important role of the
somatosensory receptors is to provide feedback to the central nervous system about joint
position, body movement, and length-tension relationships of muscle. Improved
awareness of joint position, body movement, and maintaining optimal length-tension
relationship of muscles can positively influence muscle activation.29 Therefore, the
stimulation of the somatosensory system is capable of influencing muscle performance.
This section will describe the different types of somatosensory receptors and how
stimulation of these receptors through specific therapeutic interventions facilitates
muscular activation and influences muscle performance.
2.2.1.1 Somatosensory Receptors
The soft tissues of the human body are richly innervated with several types of
somatosensory receptors. Muscle spindles and golgi tendon organs are two specialized
receptors found within musculotendinous tissue.27 Muscle spindles are aligned in parallel
to the extrafusal muscle fiber and are interspersed within a muscle belly. Muscle spindles
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are sensitive to passive changes in muscle length. Rapid stretching of a muscle activates
the muscle spindle, which in turn facilitates a contraction of the same muscle. 27 Golgi
tendon organs are another type of somatosensory receptor commonly found at the
musculotendinous junction of skeletal muscles. Golgi tendon organs are aligned in series
to the extrafusal muscle fibers and are sensitive to muscle tension developed during a
muscle contraction.27 Stimulation of the Golgi tendon organs induce a spinal reflex that
inhibits the stimulated muscle.27 Although the mechanisms that activate the muscle
spindle and golgi tendon organs are different, both receptors monitor and help maintain
adequate length-tension characteristics of the muscle that may influence muscular
strength.27
In addition to the muscle spindles and golgi tendon organs, specialized
somatosensory receptors can be found in cutaneous, fascial, ligamentous, and capsular
tissues. Table 1 summarizes the various types of somatosensory receptors based on
location and sensitivity to sensory stimuli. Pacinian corpuscles are common receptors
found in the hypodermis of the skin as well as in fascial, ligamentous, muscular, and
tendinous tissue. 27,30,31 Pacinian corpuscles are poor at responding to sustained pressure
but are very good at detecting rapid changes of mechanical stimuli, particularly
vibration.27,30,31 Ruffini endings are abundant throughout the dermis of the skin,
subcutaneous tissue, capsular tissue, and ligaments of peripheral joints. Ruffini endings
are slow adapting receptors, making them able to detect stimuli of sustained pressure.
The Ruffini endings are particularly sensitive to tangential forces that create shearing-like
stress of tissue.27,30,31 Meissner Corpuscles are receptors found in the dermis layer of skin
and are responsive to fine touch and tactile discrimination. 28,32 The most abundant
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receptors found in the skin, muscular, fascial, and ligamentous structures are interstitial
receptors. A majority of interstitial receptors serve as mechanoreceptors that respond to
mechanical tension and pressure.33 Interstitial receptors are often stimulated as a result of
stretching of skin, muscle, and fascial tissue. 34
Table 1. Peripheral Cutaneous Somatosensory Receptors
Receptor
Pacinian
Corpuscles

Location
 Muscle
 Myotendinous junctions
 Joint Capsule
 Spinal Ligaments

Stimuli
 Touch
 Rapid change of pressure
 Vibration

Ruffini
Endings




 Sustained pressure
 Shearing stress

Meissner Corpuscles




Dermis of the skin
Subcutaneous tissue
capsular
Ligaments
Dermis layer of skin






Skin
Muscle
Fascia
Ligaments

Interstitial

 Fine touch
 Tactile discrimination
 Pain
 Mechanical tension
 Pressure

2.2.1.2 Influence of Somatosensory Receptors on Muscle Performance
The influence of somatosensory receptors on muscle performance is complex. 27
The integration of sensory input to muscular output may best be explained by the final
common input hypothesis.35 Based on the final common input hypothesis, sensory
receptors from cutaneous, muscular, and articular sources, in addition to the motor
centers of the central nervous system converge upon the gamma motor neurons. 35 The
gamma motor neurons innervate muscle spindles, maintaining the sensitivity of the
spindle to changes in length as the muscle shortens during contraction.27 Once activated,
the muscle spindle acts upon muscle fibers via the alpha motor neuron. According to the

16

final common input hypothesis, motor function can either be facilitated or inhibited by the
input received from the somatosensory system.35 Whether the muscle is facilitated or
inhibited may depend on the type of stimulation and ultimately the type of somatosensory
receptor that is transmitting the input to the central nervous system.30
Stimulation of somatosensory receptors can also influence muscle performance
through stimulation of the autonomic nervous system. The autonomic nervous system
controls hormonal responses, perfusion, and blood glucose levels that may influence
force generation of voluntary muscle contraction.36 Stimulation of somatosensory
receptors has been suggested to trigger sympathetic nervous system responses,37 while
other sources report an increase of parasympathetic responses.33 The type of stimulation
received by the somatosensory receptors may ultimately determine whether the
sympathetic or parasympathetic nervous systems are stimulated. Static pressure has been
shown to lower arterial blood pressure suggestive of parasympathetic nervous system
stimulation.33 Slow rhythmic stroking of soft-tissue activates the parasympathetic nervous
system, reducing muscle tone,38 skin temperature, and activation of the muscle spindle.30
Conversely, tactile pressures applied with strong and rapid manipulation of soft-tissue
activates a sympathetic nervous system response capable of inducing muscle
contraction.30,39 The stimulus imparted by an Astym® treatment resembles the stimuli
described for triggering sympathetic nervous system activation, but the effect of Astym®
treatment on activation of the sympathetic nervous system has not been investigated.
2.2.1.3 Therapeutic Applications of Neuromuscular Facilitation
The facilitation of muscle performance through somatosensory stimulation has
been the proposed physiologic mechanism behind many therapeutic interventions dating
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back to the middle of the twentieth century.40,41 Dr. Margaret Rood developed methods to
either facilitate or inhibit muscle activation with the purpose of normalizing motor
function.40,41 The therapeutic interventions introduced by Dr. Rood became known as
neurodevelopmental therapy.40,41 Neurodevelopmental therapy is based on the principle
that therapeutic interventions provide a sensory stimulus that targets a specific sensory
receptor to elicit a desired response.40,41 Rood proposed that therapeutic interventions
that include rapid tissue stroking, fast brushing of the skin, and vibration facilitate muscle
contraction.40,41 Although these therapeutic interventions have been commonly employed
in clinical settings, there is limited evidence to support the idea that the techniques are
capable of facilitating neuromuscular function and enhancing muscle performance.
2.2.1.3.1 Tactile Stimulation
According to the original theories described by Rood 41, fast brushing of the skin
causes a stimulation of the same somatosensory receptors that are sensitive to pain. Rood
believed the sensory stimulation from fast brushing would influence the muscle spindle to
have a facilitatory effect on muscle activation.41,42 The facilitation of the muscle was
believed to last up to 40 minutes after cessation of fast brushing.41,42 However, a study
performed by Mason42 revealed no clear conclusion of the effect of tactile stimulation
through fast brushing on muscle activation measured by electromyographic activity and
muscular strength as measured by peak force production of the stimulated muscle.
Mason42 tested the effect of 5 seconds and 30 seconds of brushing of the skin overlying
the gastrocnemius muscle at speeds of 5, 180, and 360 revolutions per second in healthy
subjects. The peak force and electromyographic activity of the gastrocnemius muscle in
response to an Achilles reflex was recorded sequentially at 30 seconds following the
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cessation of brushing and every 5 minutes thereafter for 30 minutes. The results of the
study indicated that electromyographic activity of the gastrocnemius muscle was not
significantly different from a control condition that did not receive the fast brushing
stimulus. The peak force production, however, was significantly different according to
the analysis of variance, but was unable to show a significant effect for the different
speeds, duration, and elapsed time from the fast brushing stimulus. In a similar study,
Wood et al.43 demonstrated an inhibitory effect of the gastrocnemius-soleus muscle reflex
in response to fast brushing among a group of healthy subjects. Conversely, Matyas et
al.44 demonstrated a significant effect of fast brushing on maximal volitional contraction
of the hamstrings and quadriceps muscles among subjects with hemiplegia. These
findings were consistent with those described by Garland and Hayes 45 who reported
improved voluntary contraction of the tibialis anterior muscle in response to fast brushing
among a group of individuals suffering from foot drop. Based on the findings of these
research studies it appears that the response to fast brushing in healthy subjects is
equivocal or inhibitory to muscle activation. On the contrary, subjects with neurologic
impairment experience a facilitatory muscle response.42-45 The authors of these studies
concur that the influence of sensory stimulation on muscle activation and strength is
complex and may depend on several intrinsic factors of the individual that may explain
the variable response to the stimulation.40,42-45
2.2.1.3.2 Vibration
Vibration is another sensory stimulus that has been proposed to have a facilitatory
effect on muscle performance. Therapeutic applications of vibration can be applied
locally to a single muscle-tendon complex, to an entire limb segment, or through the
entire body.46 The mechanical stimulation from a therapeutic application of vibration is
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believed to stimulate the muscle spindle complex found within the muscle tissue. The
stimulation of the muscle spindle increases excitability of motorneurons transmitting
efferent signals to the muscles that received the mechanical stimulus from vibration.46
The increase of motorneuron excitability has been substantiated with studies that
demonstrate acute increases of electromyographic activity of muscles in response to
vibration stimuli compared to control groups.47-53 The effects of vibration on cutaneous
mechanoreceptors may last for several minutes post vibration stimulation.54 Reflex
responses affecting motorneurons are also heightened following vibration stimulation
when compared to non-vibration conditions. 51,55,56
The acute effects of vibration on muscle performance, specifically muscle
strength and power, have been well documented. Bosco et al.57 studied the acute effects
of vibration on single limb squat strength in elite volleyball players. The subjects
experienced a 6-8% increase in squat strength when tested immediately following wholebody vibration. Similar findings were reported for the elbow flexor muscles as
electromyographic activity and muscle force production tested 5 minutes after vibration
treatment to the entire upper extremity showed a significant improvement compared to a
control group that did not receive upper extremity vibration.58 Issurin et al.59
corroborated these findings with approximately 10% increases in muscular strength of the
elbow flexor muscles with vibration stimulus to the entire upper extremity. Mileva et
al.60 demonstrated significantly greater muscular strength of the knee extensor muscles
during trials superimposed with a form of vibratory stimulus to the quadriceps muscles
when compared to performance without a vibratory stimulus. Conversely, de Ruiter et
al.61 demonstrated no significant effect of whole-body vibration on maximal voluntary
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isometric knee extensor force. In fact, they found an approximate 5% decrease in
isometric knee extensor force.61 Cormie et al.62 also demonstrated a decline in muscular
strength as determined by peak force during an isometric squat test. However, in the
studies by Cormie et al.62 and de Ruiter et al.61, the whole body vibration was applied
while subjects assumed a squat position. This placed the knee angle of the subjects
between 100-110° of flexion. The position would require activation of the knee extensor
muscles that could have fatigued the muscles prior to the post-treatment force testing.
Research has demonstrated that vibration applied during muscle contraction or active
exercise results in accelerated muscle fatigue.51 Therefore, differences in the application
of the vibration may explain the contradictory results found for vibration and muscular
strength. A recent meta-analysis of studies investigating the short-term effects of
vibration on muscle performance concluded that vibration has an overall positive
influence on muscular strength, specifically for the muscles involved in extension of the
knee.63 Astym® treatment is hypothesized to stimulate the same somatosensory pathways
as vibration and thus may share similar treatment effects on muscle performance.

2.2.2 Pain Modulation
Pain is defined as an unpleasant sensory or emotional experience associated with
actual or potential tissue damage.64 Pain serves as a natural warning system to protect the
body from impending damage through input from specialized receptors called
nocioceptors.65 Nocioceptors elicit pain in response to mechanical, thermal, and chemical
stimuli.65 Stimulation of nocioceptors has been shown to suppress muscle activation and
decrease muscular strength.66-68 Conversely, when stimuli from nocioceptors are abated,
muscular strength and activation is restored to pre-painful levels.69 Soft-tissue treatment
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techniques are thought to influence muscular strength by altering the patient’s perception
of pain.70 Astym® treatment has been shown to improve self-reported measures of pain
over the course of several treatment sessions.1,5-8,10,11,16,17 However, the acute effects of
Astym® treatment on pain have not been studied.

2.2.2.1 Gate-Control Theory of Pain
One possible mechanism of action through which soft-tissue mobilization
techniques might influence a person’s perception of pain is the gate-control theory of
pain. The gate-control theory of pain is based on the principle that stimulation of larger
diameter relatively rapidly conducting peripheral nerve fibers blocks painful stimuli
transmitted through smaller, slow conducting neurons that enter the spinal cord at the
same spinal level.71 Based on the gate-control theory of pain, a patient’s perception of
pain is reduced as stimuli from small fiber nocioceptors are blocked from transmitting
signals to central command centers in the brain by mechanical or electrical stimulation of
larger diameter neurons from cutaneous mechanoreceptors.71
Physical therapists commonly employ therapeutic interventions to electrically
and/or mechanically engage the mechanisms of the gate-control theory of pain in an
effort to reduce pain.71 A transcutaneous electrical stimulation device uses electric current
to stimulate large fiber, cutaneous mechanoreceptors thereby blocking signals originated
by small fiber, nocioceptors from reaching the brain and thus modulating or changing the
perception of pain.72 Hopkins et al.73 showed that experimentally-induced pain and
effusion to otherwise healthy knee joints resulted in decreased activation and strength of
the quadriceps muscle group was reversed for up to 30 minutes following application of
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transcutaneous electrical stimulation to the knee joint.73 Similarly, Pietrosimone et al.74
demonstrated significant increases of quadriceps activation among subjects with knee
osteoarthritis treated with transcutaneous electrical stimulation. Cetin et al.75
demonstrated increases of isokinetic strength of the quadriceps between 50-70% from
baseline measures following 20 minutes of transcutaneous electrical stimulation
combined with application of a moist hot pack to the knee joint. With the exception of
the study performed by Pietrosimone et al.,74 the improvements in muscle performance
coincided with a reduction of patient perceived pain that suggests therapeutic
interventions that mediate pain have the capability to acutely change muscle activation
and influence strength.
2.2.2.2 Descending Pain Suppression Mechanism
Pain suppression can also occur as unpleasant cutaneous sensations received by
the central command centers of the brain trigger responses to inhibit the painful stimuli.
When a painful stimulus is transmitted to the central nervous system, it stimulates nuclei
in the midbrain. The nuclei of the midbrain initiate activity through the descending
spinal tracts that are returning to the spinal level in which the painful stimuli was
received. This stimulus causes a release of endogenous opiates at the spinal level
receiving the painful input.70 Endogenous opiates, collectively referred to as endorphins,
are inhibitory neurotransmitters that work to blunt the transmission of painful stimuli to
the brain. Endorphins are produced by the pituitary gland and hypothalamus and are
released to the brain and spinal cord in response to pain as well as during exercise and
elevated emotional states. Soft-tissue mobilization techniques, specifically massage
techniques, have been shown to cause an increase of serum endorphins for up to one hour
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following treatment.76 Based on this information, it is possible that Astym® treatment
produces similar increases of serum endorphins that could decrease pain and result in
improved muscle activation and performance.
2.2.2.3 Theorized Effect of Astym Treatment on Pain Modulation
Astym® treatment has been shown to improve musculoskeletal sources of
pain5,8,10,11, however, the mechanisms through which pain reduction is achieved are
unknown. Soft-tissue mobilization techniques are theorized to mediate pain through the
gate-control and/or descending pain suppression mechanisms.70 Research suggests that
reduction of pain results in a reversal of muscle inhibition that results in improved
muscular activation and strength.69 To date, research that has investigated soft-tissue
treatment on acute changes in muscle activity and strength has been equivocal,77-83
however, these studies were not performed on subjects with musculoskeletal pain. There
is no existing study that has examined if a reduction of pain following Astym® treatment
affects muscular activation or strength.

2.2.3 Mechanosensitivity of Muscle Tissue
Soft-tissue mobilization techniques are thought to induce changes in cellular
functions in response to mechanical stimulation.13,14 Davidson et al.13 and Gehlsen et
al.14 studied the effect of Astym® treatment on the cellular functions of fibroblast cells.
Fibroblast cells are found in ligaments, tendons, and fascia and are responsible for
producing collagen, a structural protein that gives various soft-tissues its inherent
strength.13 The results of the research by Davidson et al.13 and Gehlsen et al.14
demonstrated that mechanical stimulation applied through Astym® treatment resulted in a
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significant increase of collagen production by the fibroblast cells in a rat model.13,14
These findings were consistent with related research that has shown that mechanical
stimulation of fibroblast cells facilitates cellular growth, increases protein synthesis,
promotes the release of growth factors, and attracts additional fibroblast cells.84-86
Other types of cells are sensitive to mechanical stimulation and may be influenced
by Astym® treatment as well. The membranes of skeletal muscle tissue contain
mechanosensitive ion channels that facilitate exchange of potassium and calcium ions
necessary to propagate muscle contraction.87 Researchers have shown that increases of
intracellular calcium within the muscle results in greater force of contraction by muscle
fibers.88-90 Conversely, a reduction of the magnitude or rate of calcium release to working
muscle cells results in decreased force of contraction.91 This intimate relationship of
calcium to muscle force production is known as the force-calcium relationship.88-90
Mechanical stimulation of various cells has been shown to increase the exchange of
calcium ions across cellular membranes.92 Mechanical stimulation of muscle cells is
believed to alter the concentration of calcium ions 87 that may increase force of muscle
contraction. Whether mechanical stimulation applied through Astym® treatment affects
the force-calcium relationship to increase muscle force production, however, has yet to be
studied.

2.2.4 Increase of blood flow
Astym® treatment causes a hyperemic response that can be seen on the surface of
the skin of the body regions that have been treated. This suggests that Astym® treatment
results in a local increase of blood flow to the treated areas. Studies have substantiated
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changes in blood flow as a result of other forms of soft-tissue mobilization.93-95 An
increase of blood flow is related to physiologic changes in soft-tissue temperature that
may enhance force output during a maximal contraction.96,97 Longworth 98 reported
increases of tissue temperature following 6 minutes of massage that was maintained for
10 minutes following treatment. Drust et al.99 demonstrated increased intramuscular
temperature of the quadriceps muscles as a response to massage. Increased soft-tissue
temperature can directly influence muscle strength. Gray et al.100 found that muscle fiber
conduction velocity is increased in muscles with an elevated temperature. An increase of
muscle fiber conduction velocity is strongly correlated with maximal force and rate of
force development of a muscle.101 Based on this evidence, it is hypothesized that Astym®
treatment may induce similar changes of blood flow resulting in increased temperature
and potential for increased force development of the treated muscles.

2.2.5 Summary of the Proposed Mechanisms for Improving Muscle
Performance through Soft-tissue Mobilization.
Evidence suggests that pain modulation, neuromuscular facilitation, increased
blood flow, and increases of intracellular calcium within muscle tissue are possible
mechanisms by which Astym® treatment may acutely increase muscle performance.
Astym® treatment may change the perception of pain experienced by the patient. A
reduction of pain can result in an improved ability of the muscle to produce force.
Astym® treatment may also stimulate neuromotor mechanisms that facilitate muscle
contraction and force production through somatosensory stimulation. Tactile stimulation
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and vibration are examples of facilitatory therapeutic techniques that have been shown to
enhance muscular strength. Perhaps Astym® treatment could provide a similar effect to
treated muscles through stimulation of the somatosensory system. Astym® treatment may
also cause changes in blood flow that increases intramuscular temperature and resultant
muscle force production. Finally, Astym® treatment may provide a stimulus to
mechanically sensitive ion channels found within muscle tissues that facilitate muscle
contraction. These physiologic mechanisms provide a theoretical framework through
which Astym® treatment may influence the motor system to improve muscular strength.
A randomized, clinically controlled trial is needed to determine if Astym® treatment has
an acute effect on muscle performance.

2.3 The Effects of Therapeutic Soft-Tissue Mobilization
Techniques on Muscle Performance
Therapeutic soft-tissue mobilization techniques are manual therapy interventions
directed at soft-tissue structures to increase joint range of motion, reduce pain, decrease
swelling, increase flexibility, or improve muscle performance. Traditionally, soft-tissue
mobilization techniques are performed with the hands of a skilled professional, however,
new soft-tissue mobilization techniques have evolved that utilize specialized instruments
to assist the therapist in administering treatment. These are collectively known as
instrument assisted soft-tissue mobilization techniques. Research suggests that noninstrumented and instrumented soft-tissue mobilization techniques may facilitate or
inhibit muscle performance, depending upon the specific technique
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employed.5,9,70,77,82,102-105

2.3.1 Instrument Assisted Soft-Tissue Mobilization
Many different types of instruments and methods have evolved for the purpose of
mobilizing soft-tissue. These techniques are known generally as instrument assisted softtissue mobilization techniques. There is limited information regarding the effects of
instrument assisted soft-tissue techniques, specifically as it relates to muscular strength.
The purpose of this section will be to examine patient outcomes in muscle performance
as a result of treatment with instrument assisted soft-tissue mobilization techniques.
Emphasis will be placed on how instrument assisted soft-tissue techniques, including
Astym® treatment, Graston® technique, “the Stick” ®, and Foam rollers effect measures of
muscular performance, specifically muscular strength.
2.3.1.1 Astym® Treatment
Improvements in muscular strength at the conclusion of care have been
documented in studies reporting the outcomes of Astym® treatment. In a clinically
controlled trial, Wilson et al.17 explored the effect of Astym® treatment on patients
diagnosed with patellar tendinopathy. The patients were randomized into an Astym®
treatment group or a control group. The Astym® treatment group (6 males, 4 females)
received Astym® treatment in addition to stretching and strengthening exercises for the
lower extremity at a frequency of 2 times per week for 4 weeks. The control group (5
males, 5 females) received identical stretching and strengthening exercises 3 times per
week for 4 weeks but did not receive Astym® treatment. Muscle performance tests were
utilized to determine the success of treatment. The muscle performance tests included an
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ability to perform: 1) 6 consecutive single limb hops, 2) a bilateral squat with thighs
parallel to the floor, and 3) an eccentric step down test (lowering from a 10 inch step with
the involved lower extremity) with less than a 3/10 pain by self-reported numeric pain
scale. The results demonstrated that 100% of subjects in the Astym® treatment group
successfully performed the muscle performance tests; while only 60% of subjects in the
control group were able to successfully perform the muscle performance tests.17 The
results showed that the treatment program supplemented with Astym® treatment resulted
in superior muscle performance tests compared to a control group that performed
stretching and strengthening exercises for the lower extremity.17
Two case studies have also shown that Astym® treatment can influence muscle
performance. Haller et al. 5 documented a case of a cyclist with a 2.5 year history of
lateral epicondylalgia. Following 8 sessions of Astym® treatment in conjunction with
stretching exercises, the individual’s pain score changed from a 6/10 to a 0/10 by numeric
pain scale and her grip strength improved from 19.35 kg to 36 kg at the time of discharge
from physical therapy. Another case study reported by McCormack 9 documented the
use of Astym® treatment and eccentric exercise on tendinopathy of the proximal
attachment of the hamstring muscle group. Sixteen treatments resulted in an improvement
of muscular strength of the hamstring muscles from a 4-/5 to a 4+/5 by manual muscle
testing. 9 Each of these case studies demonstrated evidence of improved muscular
performance, specifically related to measures of muscle strength, in a treatment program
that included Astym® treatment. However, the results from these case studies should be
interpreted with caution. A case study research design limits the ability to draw
conclusions of a cause and effect relationship of the treatment intervention to the
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outcome measures and limits the generalizability of the findings to a broader
population.106 The addition of other components of care, specifically the inclusion of
progressive resisted exercise in the case studies described above, limits the ability to
attribute improvements in muscular strength to the intervention of Astym® treatment.
Therefore, it cannot be determined with certainty that Astym® treatment was the cause of
improved muscular strength of the patients documented in the case studies. It also
remains unknown if other patients with similar characteristics and complaints of
symptoms would have the same outcome that was documented in the case studies. To
date, no study has specifically examined the acute effects of Astym® treatment on muscle
strength.
2.3.1.2 Graston® Technique
The Graston® technique is an instrument assisted soft-tissue mobilization
technique that also utilizes specialized instruments to treat soft-tissue dysfunction (Figure
2).107 The purpose of the Graston® technique differs from that described for Astym®
treatment. Astym® treatment is proposed to induce biological changes at a cellular level
to promote the absorption of scar tissue and to stimulate the regeneration of soft tissues.
The purpose of the Graston® technique is to mechanically mobilize scar tissue and
breakdown adhesions that cause pain and limit function.107 In general the Graston®
technique is applied more aggressively to the specific areas of soft-tissue dysfunction,
while Astym® treatment is performed globally to the soft-tissue structures of the entire
affected limb or body segment.
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Figure 2. Instruments used for application of the Graston® technique
Despite the inherent differences in the treatment approaches of Astym® treatment
and the Graston® technique, both techniques have similar evidence of improving patient
outcomes. Isolated case reports have shown that the Gratson® technique was part of a
successful rehabilitation program in resolving symptoms of DeQuervain’s
tenosynovitis,108 compression fracture of the lumbar spine,109 plantar fasciitis,107,110,111
lateral epicondylagia,112 Achilles tendinopathy,113,114 and arthrofibrosis of the knee.102
Although these case reports demonstrate improvements in pain and self-reported
functional scores, few of these cases have reported changes in muscular strength. In a
case describing the outcome of a patient with arthrofibrosis following surgical repair of
the quadriceps tendon, Black 102 showed that quadriceps muscle performance as measured
by an extension lag during a straight leg raise maneuver, improved following a treatment
program consisting of the Graston® technique as well as joint mobilization and
strengthening exercises. Use of the Graston® technique with stretching and strengthening
exercises in the management of a 35 year-old female with a 2-year history of chronic calf
pain also resulted in modest changes in muscle performance.115 Improvements of
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plantarflexion strength from 4/5 by manual muscle test to 5/5 were documented over the
course of 9 treatment sessions. She also improved her ability to perform single-limb
heel-raises from 22 repetitions to 25 repetitions. A cause and effect relationship,
however, cannot be concluded from a case study research design and thus it remains
uncertain how much the Graston® technique can influence muscular strength.
2.3.1.3 “The Stick” ®
“The Stick” ® is described as a non-motorized massage device composed of a 24inch rod around which several individual 1-inch cylinders rotate (Figure 3). The
instrument is intended for patients to self-administer treatment by rolling the device over
the affected areas of perceived pain or dysfunction.103 Mikesky et al.103 studied the use of
“the Stick” ® on muscle strength, power, and flexibility. In this randomized, double blind
study, 30 collegiate athletes were recruited to participate and were exposed to three
different treatment protocols: a control group that received no treatment, a placebo group
that received mock electrical stimulation (electrodes placed on the leg, but never turned
on), and a treatment group using “the Stick” ® on the muscles of the lower extremity for a
total of 2 minutes. Four tests were performed immediately following the designated
treatment to represent different components of muscle performance: 1) peak torque
generated during isokinetic knee extension set at 90°/second, 2) a vertical jump test, 3)
timed speed during a 20-yard sprint, and 4) angle of flexion of the hip joint while
performing an active straight leg raise (maximum flexion angle of the hip joint with the
knee extended and ankle in neutral dorsiflexion). The order in which the tests were
administered was standardized for each testing session: 1) flexibility, 2) vertical jump, 3)
20-yard sprint, and 4) isokinetic strength. The subjects were asked to attend 3 separate
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treatment sessions spaced a week apart. A different treatment protocol was performed
each week so that by the end of the 3 weeks, each subject was exposed to each of the
three treatment protocols (control, placebo, and “the Stick” ®). At the conclusion of every
weekly treatment session, the measures of muscle performance were performed. The
researchers compared the results of the measures of muscle performance for each of the
treatment protocols using a one-way analysis of variance. The statistical analysis showed
that none of the treatment conditions, including use of “the Stick” ®, resulted in a
significant difference in the measures of muscle performance.103 The researchers
concluded that use of “the Stick” ® had no impact on facilitating improvements in muscle
performance.

Figure 3. “the Stick” ®
2.3.1.4 Foam roller
The foam roller has become an increasingly more common tool for patients to
self-administer soft-tissue treatment (Figure 4). Abels et al.116 studied the effects of selfadministered soft-tissue treatment using a foam roller on muscle performance. A 2.5minute foam roller protocol to the muscles of the lower limb was followed by the dropjump test. The researchers compared maximal vertical height displacement and
magnitude of the soleus reflex in the limb that received treatment to the limb that did not
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receive treatment. The results showed that the foam roller intervention did not have a
statistically significant effect on vertical height displacement (p=0.525) and latency of the
soleus reflex of the limb (p=0.693) when compared to the limb that did not receive the
foam roller treatment.116 Sullivan et al.117 noted improved performance of flexibility
measures with use of a foam roller protocol that did not influence maximal muscular
force production or electromyography of the treated muscles. Healey et al.118 showed
that a foam roller protocol affected self-perceived post-exercise fatigue but did not have
an impact on muscular performance as noted on a vertical jump test, isometric squat force
production, and speed on the Pro agility test. Collectively, much of the literature on softtissue mobilization using self-administered techniques with a foam roller has
demonstrated the capability to improve flexibility while having no significant effect on
acute muscle performance, specifically in regards to muscular strength.

Figure 4. Self-administered treatment of the lower extremity using a Foam Roller
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2.3.1.5 Summary of the effects of Instrument Assisted Soft Tissue Mobilization on
Muscle Performance
There is limited evidence to make definitive conclusions regarding the effect of
instrument assisted soft-tissue mobilization on muscle performance. Improved measures
of lower extremity muscle performance was found in one randomized clinical trial that
investigated the effect of a series of Astym® treatments compared to a control group that
received treatments of stretching and strengthening exercises.17 Case studies
documenting the effect of Astym® treatment and Graston® technique have shown modest
improvements in muscle performance.102,115 However, clinical trials that examined selfadministered techniques including those utilizing “the Stick” ® or foam rollers have
shown inhibitory or equivocal effects in measures of muscle performance.103,117,118 The
conflicting results from the existing literature make it unclear as to how instrument
assisted soft-tissue mobilization techniques affect muscle performance.

2.3.2 Non-Instrumented Soft-tissue Mobilization
Non-instrumented soft-tissue mobilization techniques can be defined as
therapeutic mobilization techniques applied with the skilled hands of a trained
professional for the purpose of treating pain, swelling, limited flexibility, or impaired
muscle performance that limits the functional abilities of an individual. There are many
types of non-instrumented mobilization techniques used to treat soft-tissue dysfunction,
the most common being therapeutic massage techniques. The purpose of this section will
be to explore the scientific literature that exists regarding the influence of the different
types of massage and other non-instrumented soft-tissue techniques on muscle
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performance, specifically muscular strength.
2.3.2.1 Types of Massage Techniques
There are many types of massage techniques used to treat soft-tissue
dysfunction.119 The most common techniques reported in the literature include
effleurage, petrissage, deep transverse friction massage, and tapotement.119,120 Effleurage
consists of light or gentle stroking techniques performed longitudinally along the length
of a muscle or body segment.119,121 This technique is usually performed in a distal to
proximal direction and is commonly used to sooth, relax, or comfort a patient in between
more aggressive or vigorous types of massage.119,121 Petrissage is an example of a more
aggressive type of massage technique that incorporates kneading, wringing or scooping
strokes to the soft-tissue.119,121 Petrissage techniques are generally performed more
vigorously and more rapidly than effleurage techniques with deeper pressure
administered to the underlying muscular tissues. 119,121 Deep transverse friction massage
is described as a penetrating massage technique that targets tissues deep to the
hypodermis including muscle, ligaments, and tendons. Deep transverse friction massage
is generally performed with small vigorous strokes applied through the fingertips,
perpendicular to the fiber alignment of the target tissue. This technique is designed to
induce mild tissue destruction characterized by hyperaemia and an inflammatory reaction
with the intent to reduce adherent or contracted tissue and induce tissue
remodeling.119,121,122 Tapotement refers to percussive massage techniques that may
include tapping, striking, or clapping on the recipient’s body. The purpose of tapotement
techniques is to cause vasodilation and trigger cutaneous reflexes that are believed to
increase muscular tone.121
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2.3.2.2 Effect of Massage on Muscle Performance
Several studies have investigated the effect of massage on muscle performance.
The majority of evidence suggests equivocal and potential negative influence of massage
on muscle performance. Arroyo-Morales et al. 77 studied the effects of a combination of a
20-minute massage session consisting of effleurage, petrissage, and tapotement
administered to the gastrocnemius-soleus muscle complex, hamstrings, and quadriceps
muscles on the isokinetic peak torque of knee flexor and extensor muscles. The study
found that isokinetic peak torque output of the knee extensor muscles was significantly
reduced immediately following massage treatment compared to a placebo treatment when
tested at isokinetic speeds of 240°/second and 180°/second. There were no statistical
differences noted between the placebo and massage treatment groups for isokinetic peak
torque output of the knee extensor muscles at 60°/second, 120°/second nor were there
statistical difference in isokinetic peak torque of the knee flexor muscles at any of the
tested speeds (60°/second, 120°/second, 180°/second, 240°/second).77 WiktorssonMoller et al. 82 reported similar effects of massage on isokinetic and isometric peak torque
of the knee extensor and flexor muscles. A significant decrease in isokinetic peak force
of the knee flexor muscles at isokinetic speeds of 30°/second and 180°/second and
decreased isometric peak force for the knee extensor muscle group were observed
following an average of 12 minutes of petrissage to the lower limb. McKechnie et al. 80
compared the peak torque of the plantarflexor muscle group between three different
massage treatment groups. The first group received 3 minutes of petrissage treatment to
the gastrocnemius-soleus muscle complex. The second group received 6 minutes of
tapotement treatment to the gastrocnemius-soleus muscle complex. The third group
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received a placebo treatment to the gastrocnemius-soleus muscle complex. The results
showed that peak torque did not demonstrate a significant difference for either of the
massage treatment groups compared to the placebo.80 Similar results have been reported
in studies using massage protocols that included 8-30 minutes of petrissage and
effleurage treatment. These studies failed to demonstrate improvements in variables of
muscle performance including power and peak torque.78,79,81,123,124 Arazi et al.104 studied
the effect of a 15-minute swiss massage protocol to both of the lower limbs that included
components of effleurage, petrissage, tapotement, and vibration on vertical jump, agility,
and sprint performance. Using a pre-test/post-test design, the results showed that vertical
jump, agility, and sprint performance significantly decreased immediately following
massage treatment. Mancinelli et al. 125 also demonstrated decreased performance in
agility testing with a 17-minute massage protocol consisting of effleurage, petrissage, and
vibration techniques. However, vertical jump performance demonstrated a statistically
significant improvement.125
There are only a few clinical trials that have shown an improvement of muscular
performance following massage treatment. According to Micklewright et al.,126 a 30minute massage treatment that included effleurage and petrissage techniques significantly
improved anaerobic power as determined by the Wingate Anaerobic Cycling Test when
compared to a control group that did not receive massage treatment. In a similar study,
Ogai et al. 127 demonstrated increased total power of cycling following a 10-minute
petrissage treatment to the lower extremity compared to a control group that did not
receive treatment. A 3.1% improvement of performance was noted in the massage group
compared to a 0.8% decrease of performance in the control group. In a similar study,
38

Brooks et al.16 investigated the effect of massage on grip strength after fatiguing exercise
Subjects were randomized into a massage group, a passive range of motion group, and a
control group that received no treatment. The subjects in the massage group received 5minutes of effleurage and cross-friction massage to the hand and forearm. A comparison
of the groups showed that the massage group yielded a significantly greater increase of
grip strength when compared to subjects that received passive range of motion or no
treatment at all. The authors concluded that stimulation of available motor units, an
analgesic effect, and a perceived recovery effect experienced by the subjects resulted in
improved muscular strength.128
The majority of evidence on massage and muscle performance suggests that
massage has a negative influence on muscle strength and power. With the exception of
the study performed by Brooks et al.,128 massage has shown little value in recovery of
strength following muscle fatigue.78,79,81,123,124,129,130 Analysis of the literature should
consider the methods of massage employed by these studies. The majority of the articles
reviewed utilized protocols of massage of varying techniques and times. Most of the
techniques incorporated effleurage and petrissage. These specific massage techniques are
proposed to have inhibitory effects on the excitability of motorneurons.105 Tapotement
techniques, however, are believed to have an excitatory effect on motor neurons.
McKechnie et al.80 provided a study that compared a group that was treated with a
massage protocol consisting of only tapotement techniques compared to a group that
received petrissage techniques. If tapotement techniques do provide an excitatory effect
on motor neurons, then it was not enough to elicit significantly greater production of peak
torque in the plantarflexor muscles of the ankle when compared to a group that received
39

petrissage treatment.80 The collective findings from studies on the effect of massage on
muscular strength suggest that massage does not result in an increase of muscular
strength.
2.3.2.3 Active Release Therapy®
Active Release Therapy® is a non-instrumented soft-tissue mobilization technique
that uses sustained longitudinal manipulation of soft tissue in cooperation with active and
passive motion of the individual’s body.131 Active Release Therapy® is indicated in the
treatment of various soft-tissue disorders, including shin splints, sciatica, carpal tunnel
syndrome, plantar fasciitis, and tendinopathy.83 Because Active Release Therapy®
involves conscious activation of muscle tissue by the patient, it is believed to directly
affect muscle performance.131. Drover et al.83 studied the effect of Active Release
Therapy® on the maximal force production of the quadriceps muscle group. The results
demonstrated that Active Release Therapy® did not have a significant effect to either
increase or decrease force production of the quadriceps muscle group. Although Active
Release Therapy® requires conscious muscle activation by the individual, the techniques
also place the muscle tissues in a lengthened position that stretches the muscles.131
Stretching of muscle tissue has been shown to cause a decrease in muscle performance,
specifically measures of muscular strength.132-136 Based on the results described by
Drover et al.,83 it may be concluded that any facilitory effect elicited by stimulation of the
somatosensory system during Active Release Therapy® is negated by an inhibitory effect
caused by lengthening and stretching of the muscle tissue.
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2.3.2.4 Summary of Non-Instrumented Soft-Tissue Mobilization Techniques
The majority of evidence presented on non-instrumented soft-tissue mobilization
techniques suggests a negative or equivocal effect on muscle performance. The evidence
from clinically controlled trials studying various types of massage techniques indicates a
negative impact on multiple measures of muscle performance.78,79,81,123,124 Active
Release Therapy® combines soft-tissue mobilization with active and passive lengthening
of the treated tissues. A clinically controlled trial demonstrated no significant change in
muscle performance as a result of Active Release Therapy®.83 The summary of the
literature suggests that, depending on the technique used, non-instrumented soft-tissue
mobilization has a negative or equivocal influence on muscle performance.

2.3.3 Comparing Astym® Treatment to Other Therapeutic Soft-Tissue
Mobilization Techniques
Based on the review of therapeutic soft-tissue mobilization techniques, it remains
unclear how Astym® treatment will influence muscular strength. There are conflicting
results presented in the existing literature on the effect of soft-tissue mobilization
techniques on muscle strength. The contradictory findings may be explained by the
differences between the specific techniques.
The use of Astym® instruments may enable greater pressure to be applied to the
tissues during treatment. Gehlsen et al.14 found that measures of fibroblast cell function
were greatest for the treatment condition in which the greatest amount of pressure was
applied through the Astym® instruments during treatment. Although the effect of

41

pressure applied with the Astym® instruments has yet to be studied on muscle tissue,
research presented by Kukulka et al.137 reported a 10-15% increase of motorneuron
excitability in response to deep pressure applied to the muscle belly. Astym® treatment
and the Graston® technique both use hand-held instruments to administer deep pressure to
the targeted treatment areas. Although the strength of the evidence is weak, the existing
evidence suggests that the Graston® technique 102,115 and Astym® treatment 5,9,17 have a
positive influence on muscle strength, whereas soft-tissue mobilization techniques that
require less treatment pressure, such as effleurage and petrissage, have an equivocal or
inhibitory effect on muscle performance.77,78,81,82,123,124. Differences in the pressures used
for these techniques may explain the contradictory findings.
The speed of which the soft-tissue mobilization is administered may also have an
influence on muscular strength. The strokes applied with the Astym® instruments are
administered at an approximate rate of 6-8 inches per second. 12 This provides a faster
pace of soft-tissue mobilization compared to the techniques described for effleurage,
petrissage, foam roller, “the Stick”, and active release therapy that are performed with
slower strokes and were found to have an equivocal or inhibitory effect on muscle
strength.77,78,80,82,83,103,116,123,124 Goats121 suggests that the speed in which massage strokes
are administered can influence whether an excitatory or inhibitory effect on muscle
contraction is produced. Quicker, more vigorous strokes are believed to be excitatory
while slower strokes are thought to be inhibitory to muscle contraction.121 Slower
massage strokes and techniques are also thought to stimulate the parasympathetic nervous
system. Stimulation of the parasympathetic nervous system will lower heart rate and
blood pressure and promote muscle relaxation.30 Fast and vigorous cutaneous stimulation,
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conversely, stimulates the sympathetic nervous system and promotes muscle excitation.30
In contrast to effleurage, petrissage, foam roller, “the Stick” ®, and Active Release
Therapy® techniques, Astym® treatment may act to stimulate the sympathetic nervous
system, resulting in a short-term improvement of muscle performance.
Astym® treatment also differs from other soft-tissue mobilization techniques in
that the treatment is administered to the entire limb or body segment.12 As a result,
Astym® treatment may stimulate a broader range of muscles, including agonist muscle
groups found within the kinetic chain. With the exception of massage, none of the other
soft-tissue mobilization techniques described are used to treat regions other than the
specific area of pain or injury. It is possible that a more global approach in treatment
may result in enhanced recruitment of muscle groups that ultimately increase measures of
muscular strength.
The acute effects of Astym® treatment on muscle strength remain unclear. There
are unique aspects of Astym® treatment that are different from other soft-tissue
mobilization techniques that may initiate physiological mechanisms to enhance muscular
strength. Astym® treatment is performed with generally greater pressure, speed, and a
globally wider area of treatment compared to other soft-tissue mobilization techniques.
These factors are believed to have a positive influence on muscular strength, but must be
further explored in a clinically controlled trial that investigates the effects of Astym®
treatment on muscular strength.
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Chapter 3
Methods
3.1 Experimental Design
A double-blinded, repeated measures design was used to investigate the effect of
Astym® treatment on acute muscular strength of the lower extremity. The dependent
variable of interest was the maximal force generated during a unilateral isometric squat
test. The independent variable of interest was the treatment received by the subjects: 1)
Astym Treatment - received a lower extremity Astym® treatment 2) Control-received no
treatment; 3) Placebo-received a sham Astym® treatment. Subjects were randomly
assigned to receive the control, placebo, or Astym® treatment intervention and were
blinded to the treatment of their assigned group. The primary investigator (brk)
performed the control, placebo, or Astym® treatment interventions. A second
investigator (lb), blinded to the treatment, administered the pre- and post-treatment
isometric squat tests. Both investigators remained blinded to the results of the isometric
squat tests until the post-treatment tests were completed for all subjects.

3.2 Subjects
A total of 45 subjects between the ages of 18 to 65 years that met the
inclusion/exclusion criteria were recruited from the outpatient facilities of Tri-State
Physical Therapy, Seven Fields, Pennsylvania. Sample size estimates were projected
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based on data from a pilot study (see section 3.6). Potential subjects were informed of
the study by front office staff of Tri-State Physical Therapy during the subject’s first
appointment and presented the individual with an informational flyer highlighting the
purpose and procedures of the study. Recruitment of subjects continued until each group
had 15 subjects.
Selection criteria for subjects included: 1) males or females aged between 18-65
years, 2) a referral from a medical doctor for physical therapy services for a
musculoskeletal injury/condition to the lower extremity, and 3) no complaints of bilateral
symptoms to the lower extremities. Exclusion criteria included: 1) medical history of
hemophelia or other clotting disorders of the blood; 2) medical history of cardiovascular
disease including those with previous cardiovascular surgery and uncontrolled
hypertension; 3) current use of prescription blood thinners (e.g. Lovenox, Coumadin); 4)
a history of metastatic disease; 5) neuropathy of the lower extremity; 6) current
complaints of lumbar or shoulder symptoms; and 7) an active infection (or taking
medication for an infection). All subjects were asked to read and sign an informed
consent form approved by the Duquesne University Institutional Review Board and to
complete the Lower Extremity Functional Scale to objectify functional limitations caused
by their condition. Subjects that scored below a score of 40 or above a score of 70 points
out of a possible 80 points on the Lower Extremity Functional Scale were excluded from
the study. Once subjects consented to the study and completed study-related paper work
they performed strength testing as described under procedures (section 3.4). Subjects
with less than a 10% deficit in maximum force output during an isometric squat test when
compared to the uninvolved side were excluded from further testing. Testing during a
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pilot study determined that less than 10% of subjects with a musculoskeletal pathology of
the lower extremity do not have a strength deficit as determined by an isometric squat test.
Subjects that did not tolerate the Astym® treatment as described in the procedures were
also excluded from the study. Data from a pilot study determined that less than 1% of
subjects do not tolerate Astym® treatment.

3.3 Instrumentation
Maximum force output during an isometric squat test was measured using a
computerized leg press machine (Figure 5) equipped with a load cell (CDM Sport; Fort
Worth, TX). The load cell was tested by the manufacturer and demonstrated less than
0.02% error for repeatability, zero balance, creep, non-linearity and hysteresis.138 Data
from a pilot study demonstrated excellent criterion validity for the computerized leg press
machine to a digital force dynamometer with a Pearson correlation coefficient of 0.99.
The analysis revealed the Typical Error of the Estimate to be 10.69 Newtons (95% CI:
8.13-15.62 Newtons). A detailed description of the testing performed during a pilot study
to establish validity of the measurement is found in Appendix A. Measurement of force
production during an isometric squat test has demonstrated test-retest reliably of 0.97.139
However, there is no published literature documenting the reliability of the specific
computerized leg machine used in this study. An investigation during a pilot study to
establish the test-retest reliability of the computerized leg press machine is presented in
Appendix B. An intra-class correlation coefficient of 0.99 indicated excellent test-retest
reliability of the computerized leg press machine used in this study. The standard error of
the measurement was determined to be 2.7% change with a minimal detectable change of
7.5% change.
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Figure 5. Patient performing a maximal isometric squat test on the Monitored Rehab
Systems Computerized Leg Press Machine.

3.4 Procedures
All procedures were identical for each subject. Demographic information was
collected including age, height, weight, gender, lower extremity-dominance, and
musculoskeletal diagnosis as determined by assimilation of a physician prescription and
office notes, current subjective complaints/symptoms, and objective findings from
physical therapy examination. Subjects filled out a medical history form that included
items specific to the exclusion criteria. The subjects also filled out a self-reported
functional questionnaire containing the numeric pain scale (0-10) and the Lower
Extremity Functional Scale. The numeric pain scale and Lower Extremity Functional
Scale are commonly used in research and clinical settings to assess a patient’s severity of
pain and the functional impact of their injury to the lower extremity.140,141 The numeric
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pain scale has demonstrated adequate test-retest reliability (r=0.63) 142 and established a
minimal detectable change of 3 points.143 The Lower Extremity Functional Scale has
demonstrated test-retest reliability of r=0.94, construct validity to the Short Form-36
physical function score (r=0.80), and a minimal detectable change of 9 points.140 Once
the subject completed the forms, they were asked to ‘warm-up’ by cycling at a selfselected pace on a lower body ergometer (Sports Art c530 Lower Body Ergometer,
Woodinville, WA) for five minutes.
Next, maximum isometric force during a squat test was measured for each lower
extremity using a computerized leg press machine (CDM Sport; Fort Worth, TX). The
lower extremity that was tested first was randomly selected for each subject by a coin
flip. The leg press was adjusted for the designated lower extremity such that the subject’s
knee joint was placed and maintained at 70° of knee flexion as determined by a standard
8-inch goniometer (AliMed 5055 - Med. International Standard 8-in. Goniometer,
Dedham, MA). The test-retest reliability for goniometry of the knee joint has been
reported at r=0.80.144 Foot position was standardized on the footplate of the leg press so
that the bisection of the foot, ankle, and hip joints are in alignment in the sagittal plane
and the crest of the tibia is parallel to the floor. A testing protocol as described by Carcia
et al.138 was utilized to collect maximum force output during the isometric squat test. The
subjects were asked to push through their heel against the footplate of the leg press a total
of five times. The first repetition was performed at approximately 50% effort, the second
at 75% effort, and the remaining three repetitions at 100% effort. The average of the
maximum force output (Newtons) produced during the final three trials was used to
represent the subject’s maximal force output during an isometric squat test. An
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investigation during a pilot study performed prior to the initiation of this research study
demonstrated no evidence of a learning or fatigue effect utilizing a 1:10 work/rest ratio
over ten consecutive trials on the same lower extremity (Appendix C). Pain was
monitored before and after isometric testing using the numeric pain scale. Once the
testing had been completed on the designated lower extremity, the opposite lower
extremity was tested using the same testing procedures. Subjects that did not
demonstrate greater than a 10% deficit of the involved side compared to the uninvolved
side were not considered to have a significant strength deficit caused by their injury and
were dismissed from the study.
Next the subjects were randomly assigned to the control, placebo, or treatment
group. Random assignment to the groups was determined using a random numbers
generator (http://www.graphpad.com/quickcalcs/index.cfm) to create three equal groups
of 15 subjects. The treatment group received Astym® treatment to the muscles of the
anterior and lateral compartments of the leg, the gastrocnemius/soleus muscle complex,
the quadriceps muscle group, the hamstrings muscle group, the gluteus maximus, and the
gluteus medius muscles on the involved side as described by the Astym® Clinical
Manual.12 This technique includes two sets of strokes that were performed with the
Astym® instruments in both proximal to distal and distal to proximal directions. A set of
strokes covered the entire width and length of the muscle groups mentioned above from
origin to insertion. The Astym® treatment was performed as the edge of the instruments
indirectly contacted the fascial and musculotendinous tissues deep to the skin and
subcutaneous tissue. The indirect contact of the instruments with the underlying fascial
and musculotendinous tissues present with a discernable texture that is different from the
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texture appreciated from contacting only the skin and superficial fascia.12 The difference
in the texture that can be appreciated by the therapist determines the appropriate amount
of pressure applied through the instruments to mechanically stimulate the targeted
underlying soft-tissue structures.12 Individuals that are lean require less pressure through
the instruments to indirectly contact the ligamentous, deep fascial, muscular, and
tendinous tissues that are deep to the superficial fascia.12 Because each individual
possess a different amount of adipose tissue within the superficial fascia, the exact
amount of pressure applied through the instruments varies according to each individual’s
body composition. However, indirect contact of the instruments with the muscle, tendon,
deep fascia, and ligamentous tissues as determined by the unique texture that these
structures provide remains consistent regardless of body composition of an individual.
Therefore, each Astym® treatment provides a consistent stimulation of the muscle,
tendon, deep fascia, and ligamentous structures despite variability in body composition
between individuals. The speed of the strokes over the musculotendinous structures was
consistent at 6 inches/per second. 12 The investigator performing the Astym® treatment
(brk) has been certified in the technique and has over 3 years experience administering
the technique for lower extremity musculoskeletal dysfunction. Although the treatment is
not intended to be painful, the investigator monitored the subject’s comfort level during
treatment with a post-treatment numeric pain scale rating. Pain that exceeded a 7/10 on
the numeric pain scale or any verbal or non-verbal indication by the subject that
suggested they were not comfortable with the treatment resulted in an immediate
termination of the treatment and the subject was withdrawn from the study.
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The control group did not receive any treatment and was asked to sit on a
treatment table for 12 minutes. Twelve minutes represented the average time it took to
perform an Astym® treatment to the lower extremity as determined during a pilot study.
The placebo group received a sham Astym® treatment. The sham treatment was
analogous to an effleurage massage with the Astym® instruments. The sham treatment
differed from the actual Astym® treatment only in the pressure administered by the
investigator and the treatment-edge of the instrument used to administer the treatment
(Figure 6). The primary investigator (brk) glided the non-treatment edge of the Astym®
instruments over the skin of each of the treatment areas previously described for the
Astym® treatment group. Pressure through the instruments was light enough to avoid the
texture felt through indirect contact of the fascial and musculotendinous structures deep
to the subcutaneous layer with the Astym® instruments. The direction, number of
strokes, and speed of the strokes remained consistent with that previously described for
the Astym® treatment group and continued for approximately 12 minutes.

Α

Β

Figure 6. Treatment edge used for the A) Astym® treatment versus
the B) Sham treatment.
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Once the designated treatment intervention was completed, the subject was
retested on the computerized leg press machine using the identical testing procedures as
described above. A second investigator (lb) blinded to the type of treatment the subject
received administered the isometric squat tests. The investigator performing the Astym®
treatment did not have access to test results until testing was completed for each subject.
Once the post-test was complete the subject satisfied the obligations of the research study
and resumed the normal course of his/her care as determined by the physical therapist.

3.5 Statistical Analysis
All data was entered into SPSS Version 20 (SPSS Inc.; Chicago, IL) for statistical
analysis. Descriptive statistics (means /standard deviations/range) of age, height, weight,
self-reported functional score, pre-treatment pain rating, and post-treatment pain rating of
the subjects was reported and compared between groups with an analysis of variance.
The frequency of gender and the medical diagnoses by type (musculotendinous versus
non-contractile) and region (proximal portion of the lower limb versus distal portion of
the lower limb) for each respective treatment group was compared using a chi-square
analysis. The percent change of maximum force output from pre-test to post-test was
calculated by the following formula:

Post-Test - Pre-Test
Pre-test

X 100 = Percent Change
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The mean of the percent change for each group (Control, Placebo, Astym®
treatment) was compared using a one-way analysis of variance with a predetermined
alpha set at 0.05. A Tukey’s post-hoc analysis was then used to determine which groups
were statistically different from each other.

3.6 Power Analysis
Data from a pilot study were collected to determine an appropriate sample size for
this research project. Using the data collection procedures described above, the percent
change of maximum force output was collected for 12 volunteers that received the
control treatment, 12 volunteers that received the placebo treatment, and 12 volunteers
that received the Astym® treatment. The mean and standard deviation of the percent
change of maximum force output from each group is presented in Table 2. The data were
used to determine the mean difference and the effect size of the control and placebo
groups to the treatment group. The mean differences and effect sizes are presented in
Table 3. A commercially available power analysis software program (JMP Pro 10; Cary,
North Carolina) was used to calculate the sample size needed to obtain 80% power with
alpha set at 0.05 based on the smallest effect size (Astym®-Control) determined from the
pilot study data. The results of the power analysis concluded that a sample size of 15
subjects per group was needed to detect a minimal difference of 14% between the groups.
The results of the pilot study testing also demonstrated that 20% of prospective subjects
did not meet the exclusion criteria and less than 1% of subjects did not to tolerate the
Astym® treatment. Based on this estimate, we anticipated that a total of 54 subjects
would be needed to meet the required minimum of 15 subjects per group.
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Table 2. Pilot Study Data: Mean and standard deviation of the percent change of
maximum force output according to treatment group.
Group
Astym®
Placebo
Control

Number of Subjects
12
12
12

Mean % Change
19
1
5

Standard Deviation
17
10
9

Table 3. Pilot Study Data: Mean differences and effect size of group comparisons.
Group
Astym® - Placebo
Astym® - Control

Mean Difference
18%
14%

Effect Size
0.54
0.46
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Chapter 4
Results
4.1 Subjects
A total of 59 subjects enrolled in the study. There were 14 subjects that did not
meet the exclusion criteria. A flow diagram of the subjects enrolled in the study is
represented in Figure 7. Ten subjects were excluded from the study because they did not
exhibit a 10% strength deficit of the involved side compared to the uninvolved side, 2
subjects scored greater than 70 points on the Lower Extremity Functional Score, 1 subject
had a medical history of low back pain within the past 6 months, and 1 subject was taking
medication for an infection that excluded them from participating in the study.

Figure 7. Flow diagram of the subjects enrolled in the study.
Assessed for Eligilbility
(n=59)

Met Inclusion/Exclusion
Criteria
(n=45)

Excluded
(n=14)

> 70 points on Lower
Extremity Functional Score
(n=2)

<10% deficit of maximal
force output compared to
non-involved side
(n= 10)

Complaints of Low Back
Pain
(n=1)

Infection (n=1)

Randomized

Astym Treatment Group (n=
15)

Placebo Group
(n= 15)

Control Group
(n= 15)
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Data were collected on a total of 45 subjects. The average age, height, weight,
self-reported functional score, pre-treatment pain rating, post-treatment pain rating, and
involved side to uninvolved side strength deficit is reported according to each respective
treatment group in Table 4. The analyses of variance demonstrated no statistical
difference between the treatment groups for age (p=0.19), height (p=0.60),
weight(p=0.72), self-reported functional score(p=0.99), pre-treatment pain
rating(p=0.85), post-treatment pain rating(p=0.08), and involved side versus uninvolved
side strength deficit (p=0.56). Gender, lower extremity dominance, and involved side
ratios of the subjects are also organized according to treatment group in Table 4. A chisquare analysis demonstrated no significant difference in the female to male
ratio(p=0.48), lower extremity dominance ratio(p=0.76), or involved side ratio(p=0.77)
for the subjects between the three treatment groups. Diagnoses were also not statistically
different between treatment groups according to the region (distal or proximal; p=0.71)
and type(musculotendinous or non-contractile; p=0.69) (Table 5). The frequency of
gender, lower extremity dominance, and diagnosis of the subjects according to treatment
group is reported in Appendix D.
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Table 4. Mean and standard deviation of age, height, weight, self-reported functional
score, pre-treatment pain rating, post-treatment pain, and involved side to uninvolved side
strength deficit according to treatment group.
Astym®
(mean+SD)

Placebo
(mean+SD)

Control
(mean+SD)

TOTAL
(mean+SD)

42+12
166+13
68+11
60+10
2+2

43+13
168+12
70+14
60+9
2+2

35+12
170+9
75+20
60+8
3+2

40+13
168+11
71+15
60+9
2+2

2+2

3+2

3+2

3+2

4:1
14:1

3:2
13:2

2:1
14:1

31:14
41:4

3:2

7:8

8:7

24:21

Age (years)
Height (cm)
Weight (kg)
Functional score (0-80 points)
Pre-treatment Pain Rating
(0-10)
Post-treatment Pain Rating
(0-10)
Gender (Females:Males)
Lower Extremity Dominance
(Right:Left)
Involved Side (Right:Left)
SD = standard deviation.

Table 5. Frequency of Diagnoses by Region and Type According to Treatment Group.

Diagnosis by Region
Hip
Thigh
Knee
PROXIMAL TOTAL
Leg
Ankle
Foot
DISTAL TOTAL
Diagnosis by Type
Musculotendinous
Non-Contractile

Astym®

Placebo

Control

TOTAL

2
2
6
10
0
3
2
5

0
6
6
12
1
0
2
3

2
3
6
11
0
2
2
4

4
11
24
33
1
5
6
12

5
10

5
10

7
8

17
28
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4.2 Statistical Results
A one-way analysis of variance was conducted to explore the effect of Astym®
treatment on maximal force output by comparing a percent change in the maximal force
output among subjects that received an Astym® treatment, control treatment, or a placebo
treatment. There was a significant effect of the percent change of maximal force output
at the p<0.05 level for the Astym®, placebo, and control treatment groups [F(2,42) =
7.91, p = 0.001]. The partial eta-squared calculated to determine effect size was η2 =0.27.
Tukey’s post hoc analysis showed that the percent change of maximal force output was
significantly greater in the Astym® group that improved from 994 Newtons to 1150
Newtons (15+18%change) compared to the placebo group that decreased from 965
Newtons to 918 Newtons (-6+11%change) and the control group that decreased from
1043 Newtons to 972 Newtons (-1+17%change). No significant difference was noted
between the control and placebo groups (p=0.68). Table 6 summarizes the analysis of
variance. Table 7 presents the mean and standard deviation of the percent change of
maximum force output according to treatment group and Table 8 compares the mean
differences and the level of significance (p-value) between each of the group
comparisons. The raw data describing age, height, weight, Lower Extremity Functional
Score, involved versus uninvolved strength deficit, pre and post-treatment pain levels,
pre-treatment force output, post-treatment force output, and percent change in force
output is reported in Appendix E.
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Table 6. Summary table for analysis of variance for percent change in maximal force
output (Newtons).
Source

df

Sum of
Squares

Mean Square

F

p

η2

Between

2

3902.53

1951.27

7.91

0.001

0.27

Within Groups

42

10366.28

246.82

TOTAL

44

14268.80

Groups

Table 7. Mean, standard deviation, and range of the pre-treatment force output, posttreatment force output, and percent change of maximum force output according to
treatment group.
Group

Pre-treatment Force
Output (Newtons)
Mean SD
Range
527
354Astym 994
2465
533
371Placebo 965
1936N
646
212Control 1043
2672
SD=Standard Deviation

Post-Treatment Force
Output (Newtons)
Mean SD
Range
1150
630
4752909
918
515
3501861N
972
503
2342128

Percent Change in
Force Output (%)
Mean SD
Range
15
18
-30 35
-6
11
-38 10
-1
17
-31 29

Table 8. Mean differences of group comparisons.
Group
Astym® - Placebo
Astym® - Control
Control - Placebo

Mean Difference
21%
16%
5%

Significance (p-value)
0.001
0.014
0.675
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Chapter 5
Discussion
5.1 Introduction
The purpose of this study was to determine if Astym® treatment administered
to the lower extremity would result in an acute change of maximal force output during a
unilateral isometric squat test among subjects presenting with weakness associated with a
musculoskeletal injury to the lower extremity. The group of subjects that received
Astym® treatment was hypothesized to produce a significantly greater percent change in
pre-treatment to post-treatment maximal force output than the subjects that received no
treatment (control) and the subjects that received a sham Astym® treatment (placebo).
The control and placebo treatment groups were hypothesized not to be statistically
different in the percent change of maximal force output produced during a unilateral
isometric squat test. The results of the current study supported both hypotheses. Subjects
that received Astym® treatment increased maximal force output of the lower extremity
immediately following treatment by an average of 15% from pre-treatment values. The
percent change in maximal force output (Newtons) was significantly greater for the
subjects that received Astym® treatment compared to the placebo (p=0.001) and control
(p=0.01) treatment groups. The placebo treatment and a control treatment were found not
to be statistically different (p=0.68) and averaged a negative change of maximal force
output by 6% and 1%, respectively.
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This discussion will provide additional analysis on the results of the current
study. Specifically, the discussion will explore the potential mechanisms that may
explain the observed increase of maximal force output following Astym® treatment and
compare the effect of Astym® treatment on muscular strength to other interventions
including joint mobilization, vibration, massage, and other forms of instrumented softtissue mobilization that may share similar mechanisms to affect muscle performance. The
clinical significance of the results of the study will be discussed as well as consideration
for the limitations of the study that may affect the interpretation of the results of the
current study. The discussion will conclude with suggestions for possible future
investigations stemming from the results of the current study.

5.2 Percent Change in Maximal Force Output
The main finding from the current study was that subjects that received Astym®
treatment improved maximal force output (Newtons) of the lower extremity by an
average of 15% immediately following treatment. This was significantly greater (p<0.01)
than the average 1% and 6% decrease in maximal force output (Newtons) demonstrated
in the control and placebo treatment groups, respectively. The effect size calculated for
the analysis of variance that compared the treatment groups was η2 = 0.27. The effect
size describes the magnitude of the differences between the groups.145 According to
Cohen,145 a partial eta-squared calculated for an analysis of variance that is greater than
0.14 is considered to be a “large” effect size. A partial eta-squared also describes the
proportion of variance in the dependent variable explained by the independent variable.
The calculated eta-squared (η2 = 0.27) suggests that the type of treatment received by the
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subjects in the current study explains 27% of the variance in the percent change in
maximal force output. Although this is considered a large effect size,145 greater than 70%
of the variance in the maximal force output is explained by factors other than the type of
treatment received by the subjects.
An analysis of the individual performances of the subjects may help to identify
other potential factors that may explain the variance in the percent change of maximal
force output. Figure 8 is a plot graph showing the percent change in maximal force
output of each of the subjects according to the respective treatment groups. Eleven out of
the 15 subjects that received Astym® treatment had an improvement of maximal force
production greater than the minimal detectable change of 7.5% established for the
isometric squat test during pilot testing (Appendix B).The minimal detectable change
represents an estimate of the smallest amount of change that is not due to measurement
error and may be used to determine if the individual performances were likely due to
measurement error or a true change in maximal force output.146 Conversely, only 4
subjects that received the control treatment and 1 subject that received the placebo
treatment exhibited a positive percent change in maximal force output greater than the
minimal detectable change.
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Figure 8. Plot Graph of Percent Change of Maximal Force Output by Treatment Group
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The plot graph of individual performances shows a wide dispersion of values
within the Astym® treatment group. This explains the rather large standard deviation of
the percent change in maximal force output that was computed for subjects in the Astym®
treatment group. The type and location of diagnosis may help to explain variance in the
percent change of maximal force output found in the group of subjects that received
Astym® treatment.

5.2.1 The Influence of the Location of the Diagnosis
Of the four subjects in the Astym® treatment group that did not improve beyond
the minimal detectable change, two subjects had diagnoses involving the foot and ankle
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region. A closer look at the results of the Astym® treatment group revealed that subjects
that were diagnosed with a condition affecting the proximal aspect of the lower extremity
(hip, thigh, and knee regions) tended to have a greater percent change in maximal force
output compared to the subjects with diagnoses affecting the distal portion of the lower
extremity (leg, ankle, and foot). Table 9 presents the average percent change in maximal
force output according to the location of the subject’s musculoskeletal diagnosis. This
observation could be related to the specific demands of the isometric squat test. Muscles
of the hip, thigh, and knee regions have shown greater muscle activation during a squat
compared to muscles of the leg, ankle and foot regions.147 Thus the isometric squat test
may be more likely to have a positive change in maximal force production for individuals
with a diagnosis affecting the proximal portion of the lower extremity. The current study
was not powered to perform a statistical comparison that would reveal whether the
percent change of maximal force output was indeed influenced by the location of the
individual’s diagnosis, but may provide the groundwork for a future study that
investigates the influence on the location of diagnosis on changes in muscle performance
following Astym® treatment.

5.2.2 The Influence of the Type of Diagnosis
The type of diagnoses may have also contributed to the variance in the percent
change of maximal force output within the Astym® treatment group. The subjects that
participated in the study all had diagnoses affecting the musculoskeletal system. These
diagnoses were further categorized by involvement of contractile (musculotendinous) and
non-contractile structures. Table 9 shows the mean percent change of maximal force

67

output according to diagnoses involving musculotendinous versus non-contractile
structures. The subjects in the Astym® treatment group that were diagnosed with a
musculotendinous condition had an average percent change in maximal force output of
21% versus 13% for those with a diagnosis involving non-contractile structures. Again,
an accurate statistical comparison cannot be made with the small sample size from the
current study. The findings do, however, illustrate the need to perform a future
investigation to determine the effects of diagnosis type on muscle performance following
Astym® treatments.

Table 9. Percent Change in Maximum Force Output following Astym® Treatment by
Diagnosis Region and Type.
Diagnosis Categories
Region
Type
Hip-Thigh-Knee
Leg-Ankle-Foot
Musculotendinous
Non-Contractile
Regions
Regions
Hip
15%(n=2)
Leg
NA(n=0)
Thigh
28%(n=2)
Ankle
17%(n=3)
Knee
20%(n=6)
Foot
-11%(n=2)
21%(n=5)
13% (n=10)
TOTAL 20%(n=10) TOTAL 5%(n=5)

5.3 Proposed Mechanisms Contributing to Increased Muscular
Performance Following Astym® Treatment
The mechanisms through which Astym® treatment enhances muscular
performance are unknown, but previous reports in the literature regarding other methods
of soft-tissue mobilization would suggest that Astym treatment may influence muscle
performance through modulation of pain, an increase of blood flow, neuromuscular
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facilitation, or mechanical sensitivity of calcium channels within the muscle
tissue.35,70,87,148 This section will explore possible physiological explanations as to why
subjects that received Astym® treatment demonstrated an acute improvement of muscular
strength.

5.3.1 Modulation of Pain
Pain can be a powerful inhibitor of muscle strength. 66-68 In individuals
experiencing weakness accompanied by pain, a reduction of pain will often lead to a
subsequent improvement of muscle performance.69 Therefore Astym® treatment may be
capable of influencing muscular strength by modulating the perceived pain of the
subject. Soft-tissue mobilization techniques such as Astym® treatment are theorized to
mediate pain through the gate-control and/or descending pain suppression mechanisms. 70
Under the principle of the gait-control theory of pain, Astym® treatment provides a
mechanical stimulation of the larger peripheral nerve fibers found in the soft-tissue that
block the painful stimuli transmitted by smaller nerve endings called nocioceptors.70
Astym® treatment may also trigger descending pain suppression mechanisms that cause
the release of endogenous opiates at the spinal level receiving the painful input.70 These
endogenous opiates, known as endorphins, work to blunt the transmission of painful
stimuli to the brain. Soft-tissue mobilization techniques have been previously shown to
cause an increase of serum endorphins for up to one hour following treatment.76 It is
possible that Astym® treatment could cause a release of endorphins to reduce pain that
would result in improved muscle performance.56
In the current study, pain was assessed using the numeric pain score during pre69

treatment and post-treatment isometric squat tests. The Astym® treatment group did not
show an improvement of pre-treatment (2/10) to post-treatment (2/10) pain scores. The
placebo group averaged a 2/10 pre-treatment pain score and a 3/10 post-treatment pain
score while the control group averaged a pre-treatment pain score of 3/10 and a posttreatment pain score of 3/10. Thus, the average pain scores show that the improvement of
maximal force output in the Astym® treatment group was not accompanied by a reduction
of pain reported during the unilateral isometric squat tests. Further, a majority of the
subjects in the Astym® treatment group (7/11) that demonstrated an improvement in
maximal force output did not show an improvement in their post-treatment pain scores.
The improvements of muscular strength for these subjects cannot be explained simply by
a reduction of pain reported during the unilateral isometric squat tests. The average pain
scores of the subjects in the Astym® treatment group do not suggest that pain modulation
played a significant role in an improvement of maximal force output.

5.3.2 Increase of Blood Flow
Another possible explanation for the observed effect of Astym® treatment on
acute muscle strength may be explained by an increase of blood flow to the treated
musculature. The subjects that received the Astym® treatment were noted to have a
hyperemic response to the treated areas. This was evident by a red/flushed appearance of
the color of the skin and an increase of the tissue temperature to the touch. The subjects
that received the placebo and control treatments did not exhibit a hyperemic response.
Perhaps these observations suggest that an increase of blood flow to the soft-tissues
occurred in response to the Astym® treatment. Researchers have shown that soft-tissue
mobilization techniques can cause an increase of local blood flow blood to the treated
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tissues.148 Bell 149 demonstrated that the amount of local blood flow nearly doubled from
baseline measures up to 40 minutes following soft-tissue mobilization. More recently,
Franklin et al.150 showed similar increases of blood flow in response to a massage
protocol that lasted approximately 90 minutes following treatment. Similarly,
Dubrosky93 reported increases of muscular blood flow that lasted for greater than 3 hours
after soft-tissue mobilization. An increase of local blood flow to muscular tissue causes
an increase of intra-muscular temperature that may be capable of enhancing force output
during a maximal contraction.35,39, 100, 98 Although soft-tissue mobilization techniques
have been shown to improve blood flow and muscle tissue temperature, the collective
research on the immediate effect of soft-tissue mobilization on muscle strength has been
equivocal.78,79,81,123,124 This decreases the likelihood that an increase of blood flow to the
treated muscle tissue was the primary cause of the improved maximal force output that
was observed following Astym® treatment. However, the effect of Astym® treatment on
local blood flow could be an interesting topic of further research.

5.3.3 Neuromuscular Facilitation
The observed increase in muscular strength following Astym® treatment could
also be explained by neuromuscular facilitation. Neuromuscular facilitation refers to an
increase of muscle activation through stimulation of the sensorimotor system.27,28 Astym®
treatment may provide a mechanical stimulus that is processed in the motor centers of the
central nervous system similar to what researchers have previously described for other
forms of soft-tissue mobilization.35 In response to the heightened sensory input, central
motor centers send signals to surrounding muscle tissue that result in greater muscle
activation.130 The effect of soft tissue mobilization techniques, such as Astym®
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treatment, on muscular performance may depend on several different factors including
the speed and pressure through which the soft-tissue mobilization technique is
administered.40,42-45 Based on reports in the literature that describe how rapid vigorous
stroking facilitates muscle contraction,30,40,41 the strokes applied with the Astym®
instruments could likewise have a facilitating influence on muscle contraction. However,
the influence of sensorimotor stimulation on muscular performance is complex 40,42-45 and
would require additional study to determine the exact mechanisms through which
Astym® treatment affects the sensorimotor system to improve muscle performance.

5.3.4 Mechanical Sensitivity of Calcium Channels in Muscle Tissue
The mechanical stimulation produced during an Astym® treatment may also work
directly on the muscle tissue. Muscle tissue contains mechanically sensitive calcium
channels. 87 These calcium channels regulate the amount of calcium entering the muscle
tissue and are sensitive to mechanical stimulation. The amount of calcium available to a
working muscle can determine the amount of force it is capable of producing.88-90 This
phenomenon is known as the Force-Calcium relationship.88-90 Because the amount of
calcium available to working muscles can be manipulated by mechanically sensitive
calcium channels, 87 improvements in muscular strength following Astym® treatment may
be the result of an increase of calcium to the working muscle tissue.

5.4 Comparison to Other Therapeutic Interventions
At this point in time there are no reports in the literature that address the
mechanisms through which Astym® treatment affects muscle performance. However,
72

research has been performed on therapeutic interventions such as joint mobilization,
vibration, massage, and other forms of instrument assisted soft-tissue mobilization
techniques that may share similar proposed mechanisms to influence muscle
performance. This section will compare and contrast the findings of the current study to
previously published literature that has investigated the effects of joint mobilization,
vibration, massage, and other forms of instrument assisted soft-tissue mobilization
techniques on acute muscular strength.

5.4.1 Joint Mobilization
The subjects from the current study that were randomized into the Astym®
treatment group demonstrated an average increase in maximal force output of 15%. This
increase of muscular strength is comparable to the increases in muscular strength that
have been reported immediately following joint mobilization of the lower extremity.
Yerys et al.151 studied the effects of hip joint mobilization on muscular strength of the
gluteus maximus muscle. Subjects that received grade IV mobilization of the hip joint in
a posterior-to-anterior direction experienced a 14% increase of maximal force output.
Makofsky et al.152 reported that in subjects that received grade IV hip joint mobilization
in an inferior direction had an immediate increase of hip abduction force output of
17.35%. Ghanbari et al.153 demonstrated an acute increase of maximal voluntary
isometric contraction of the knee extensors by 18.7% following grade IV posterior-toanterior mobilization of the knee joint. The improvement of strength increased to 23.6%
at 30 minutes after the treatment.153
Researchers have proposed that the changes observed in muscle performance
following joint mobilization occur in response to stimulation of mechanoreceptors found
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within the joint capsule and surrounding soft tissue structures.151 We may speculate that
Astym® treatment could also influence muscle performance through stimulation of
mechanoreceptors found in soft-tissue structures that are directly or indirectly contacted
by the Astym® instruments. Both joint mobilization151-153 and Astym® treatment have
shown to have a positive influence on maximal force output and may work through
similar physiologic mechanisms to facilitate muscle performance. Additional study is
needed to determine how manual therapy interventions including joint mobilization and
Astym® treatment affect the sensorimotor system to influence muscle performance.

5.4.2 Vibration
Vibration is another therapeutic intervention believed to stimulate
mechanoreceptors in an effort to improve muscle performance.47-53 The acute effects of
vibration on muscle performance of the lower extremity have been well documented.
Rhea et al.154 studied the acute effects of whole-body vibration on peak power output
during a squat test. Subjects that received a 2 minute whole-body vibration treatment
prior to squat testing significantly (p<0.05) increased their peak power by 5.20%
compared to a control group that rested for 3 minutes.154 Jacobs et al.155 demonstrated
average isokinetic torque generated by the knee extensors improved by 9.6% following a
6-minute treatment of whole-body vibration immediately prior to isokinetic testing. A
similar improvement of 7.8% was noted for the average isokinetic torque of the knee
flexor muslces.145 McBride et al.156 demonstrated that the inclusion of whole-body
vibration immediately prior to isometric testing of the gastrocnemius muscle resulted in a
9.4% increase in maximal isometric force compared to a control group (p<0.05).156
74

Researchers have suggested that vibration stimulates mechanoreceptors found in the
muscle, tendon, deep fascia, and joint capsule structures,46,157 in a manner similar to that
described for joint mobilization. The mechanoreceptors respond to the vibration stimulus
and send signals to the central nervous system that may reflexively increase the firing of
alpha motor neurons that are traveling back to the working muscle.46,157 This may
explain the observed increases of muscle activation and performance 46,53,157
Some researchers, however, have suggested that the improvements in muscle
performance in response to vibration are not caused by neuromuscular facilitation, but are
more likely explained by an increase of intra-cellular concentrations of calcium within
the muscle tissue.158,159 Cochrane et al.160 proposed that whole body vibration causes
post-activation potentiation, a phenomenon in which the contractile elements of muscle
tissue increase their sensitivity to intracellular calcium, thus enhancing the force
production of the contracting muscle. Cochrane et al.160 attempted to determine whether
the increases of muscular strength following whole body vibration were the result of
neural mediated effects or post-activation potentiation. The peak force generated by a
muscle-tendon reflex was used to assess the neural-mediated effects. The peak force
generated from a consistent electrical stimulus to the muscle assessed the effects of postactivation potentiation. The results showed that peak force from the electrical stimulus
increased the force production by 12.4%, while force generated from the reflex-induced
contraction changed only 0.1% and was not statistically significant. Based on these
results, the authors concluded that the changes noted following whole body vibration
were likely related to post-activation potentiation that increased the availability of
calcium to the contractile elements of muscle tissue.160

As previously described,
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calcium channels that potentiate muscle contraction have shown to be sensitive to
mechanical stimulation.87 The work of Cochrane et al.160 supports the theory that the
improvements in muscular strength following Astym® treatment could be caused by an
influx of calcium through mechanically sensitive calcium channels within muscle tissue.

5.4.3 Massage
The results of the current research project conflict with previous research
documenting the effects of massage on muscle performance. Arroyo-Morales et al.77
used a cross-over design to compare the peak isokinetic torque produced by the
quadriceps and hamstring muscles following massage versus a sham ultrasound
treatment. The peak isokinetic torque of the quadriceps and hamstring following a
massage protocol of effleurage, petrissage, and tapotement to the gastrocnemius,
quadriceps, and hamstrings muscles were not greater than the peak torque recorded
following a sham ultrasound treatment.77 In fact, isokinetic torque of the knee extensors
was 9-11% less at speeds of 240°/second and 180°/second peak following massage
compared to a sham ultrasound treatment.77 Wiktorsson-Moller et al.82 reported similar
findings. Isokinetic testing at speeds of 30°/second and 180°/second for the quadriceps
and hamstring muscle groups resulted in statistically significant decreases (equivalent to
3-10% deficits) in peak isokinetic torque following massage treatment. WiktorssonMoller et al.82 also tested the quadriceps and hamstring muscle groups isometrically and
found similar decreases in muscular strength. McKechnie et al.80 studied the effects of
massage on isokinetic testing of the plantarflexor muscle group following massage
treatment. The results showed that the peak torque of the plantarflexor muscle group did
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not significantly change and was equivocal to that of a placebo treatment that received 3
minutes of static light touch to the skin overlying the gastrocnemius muscle.80
The difference between the effects of Astym® treatment and massage on muscle
strength may best be explained by the differences between the techniques. Astym®
treatment is performed with the intent to stimulate muscle tissue.12 This requires
sufficient pressure to allow the instrument to contact the underlying muscle tissue
indirectly through the skin and superficial layer of fascia.12 Strokes applied with the
Astym® instruments are performed rapidly and with enough pressure to appreciate the
distinct texture that occurs as the instruments indirectly contact muscle tissue.12 The
massage techniques used in the research studies that investigated the acute effects of
massage on muscle strength used combinations of effleurage and petrissage techniques
that were described as slow and rhythmic.77,80,82 Effleurage is a light or gentle massage
applied over the skin.119,121 With effleurage there is no intent to indirectly contact the
deep soft-tissue structures, including the muscle tissue.119,121 This is similar to the intent
described for the placebo treatment of the current research project. Instead of the
caregiver’s hands, the placebo treatment was applied with the rounded, non-treatment
edge of the Astym® instrument. The Astym® instruments were glided lightly over the
skin without indirectly contacting the deeper soft-tissue structures including muscle
tissue. The subjects in the placebo treatment group did not demonstrate a significant
difference from the control group(p=.30), and averaged a 6% decrease of maximal force
output. The 6% decrease of muscular strength is consistent with subjects that received
massage treatment in the previously described studies.77,80,82
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However, the massage techniques described in the studies above also included
petrissage techniques.77,80,82 Petrissage is a more aggressive type of massage that may
indirectly contact muscular tissue with kneading, wringing, or scooping type strokes that
are believed to facilitate muscle function.119,121 Because effleurage and petrissage were
often combined in the massage protocols used to investigate the effects of massage on
muscular strength,77,80,82 it is unknown if the effects of petrissage facilitated or inhibited
muscular strength. McKechnie et al 80 suggested that petrissage techniques are a means
to stretch muscle fibers. Stretching of muscle fibers is well documented to cause an acute
decline in muscular performance,132-136,147 and may explain why massage can negatively
influence muscle performance. Because the instruments are moved rapidly across the
length of the muscles, there is likely no sustained lengthening of the muscle fibers during
an Astym® treatment. As a result, a decline in muscular strength similar to that found
following stretching or massage may not be expected after an Astym® treatment.

5.4.4 Instrument Assisted Soft-Tissue Mobilization
The results of the current study are also different from what has been previously
reported for forms of instrument assisted soft-tissue mobilization techniques. Mikesky et
al.103 studied the effect of the use of a device known as “the Stick” on isokinetic peak
torque of the knee extensors. Subjects were tested immediately following each of the
three treatment conditions: 1) a 2 minute self-massage of the quadriceps using the
“Stick” instrument, 2) a control intervention that received no treatment, and 3) a placebo
treatment that was described as a sham electrical stimulation treatment. The peak torque
generated by the quadriceps muscles following the “Stick” protocol (689.8 N) was not
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statistically different than the peak torque following the control intervention (687.5 N) or
following the placebo treatment (681.7 N).103 Sullivan et al.117 studied the use of a foam
roller-massager device that was administered to the hamstring muscles for 5-10 seconds
at a constant rate and pressure. The maximal force produced by the hamstring muscles
decreased up to 6% following the massage-roller treatment.117 Healey et al.118 used a
cross-over study design to investigate the effects of self-administered soft-tissue
mobilization using a foam roller compared to a control treatment that consisted of
isometric trunk exercises on measures of athletic performance. The subjects completed
two separate days of testing that included maximal force output during a squat
immediately following the designated treatment. The maximal force output produced
following the foam roller treatment to muscles of the trunk and lower extremity was not
different from the control treatment of isometric trunk exercises. The authors concluded
that the foam roller intervention to the trunk and lower extremity had no effect on
maximal force output immediately following the self-administered foam roller
treatment.118
The findings reported by Mikesky et al.103, Sullivan et al.117, and Healey et al.118
are in contrast to the results of the current study that demonstrated a 15% increase in
maximal force output following Astym® treatment. The differences in how Astym®
treatment is administered versus the other forms of instrument assisted soft-tissue
mobilization may help to explain the differences in the results. One of the major
differences was the length of time in which the treatment was administered. Mikesky et
al.103 described a 2 minute treatment time and Sullivan et al.117 described the treatment
intervention as a 5-10 second treatment over the muscle tissue. These two studies also
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isolated the treatment to include only the muscle group that was being tested for muscular
strength. Healey et al.118 described the treatment administered with the foam roller to be
30 seconds for each muscle group treated. The protocol included treatment to the
quadriceps muscle group, latissimus dorsi, hamstring muscle group, gastrocnemius, and
rhomboid muscles. Based on the description of the methods, one may conclude that the
total treatment time was approximately 2.5 minutes to complete a unilateral treatment.
Comparatively, the Astym® treatment protocol used in this study averaged 12 minutes to
complete the subject’s anterior and posterior aspects of the involved extremity. The
difference in the total time of treatment and the number of structures treated during the
session may help to explain the discrepant findings.

5.4.5 Summary of the Comparison of Astym® Treatment to other
Therapeutic Techniques
In the preceding discussion evidence was presented that supports the possibility
that Astym® treatment enhances muscle performance through neuromuscular facilitation,
an increase of calcium concentration within the muscle tissue, an increase of blood flow,
or modulation of pain. Therapeutic interventions including joint mobilization151-153 and
vibration154-156 are believed to facilitate the neuromuscular system and have shown
similar increases of maximal force output to the subjects that received Astym® treatment.
Vibration has also been shown to open mechanically sensitive calcium channels within
the muscle tissue, allowing an influx of calcium to enter the muscle tissue and improve
the ability of the muscle to produce force.88-90 Astym® treatment could have increased
calcium concentrations within muscle tissue through stimulation of these mechanically
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sensitive calcium channels to enhance muscle performance. The subjects that received
Astym® treatment experienced a hyperemic response to the Astym® treatment. An
increase of blood flow and tissue temperature associated with a hyperemic response could
have contributed to an improvement of muscle performance,97,98,100 but no study to date
has been performed to determine if Astym® treatment results in an increase of blood flow
and tissue temperature. Pain modulation was another proposed mechanism believed to
influence maximal force output following Astym® treatment. However, a majority (7/12)
of the subjects that improved muscular strength following Astym® treatment did not show
improvement of self-rated pain scores. Therefore, pain modulation cannot be considered
a likely explanation for the results of the current study.
The results of the current study are in contrast to the findings that have been
previously reported on the acute effects of soft-tissue mobilization on muscle
performance.77,80,82 There are inherent differences in the way that Astym® treatment is
administered that include the speed, the pressure, and the length of treatment when
compared to other instrument 103,117,118 and non-instrument assisted soft-tissue
mobilization techniques 77,80,82 that have shown to have a negative impact on muscle
performance. Instrument assisted techniques that more closely resemble the Astym®
treatment protocol for the lower extremity have not been studied to determine the effect
on muscular performance. Additional research is needed to determine how instrumentassisted soft-tissue techniques like Astym® treatment can be used to enhance muscle
performance.
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5.5 Clinical Significance
The results of the current study may have a clinical significance to physical
therapists treating patients with deficits in muscular strength due to a musculoskeletal
condition. To put a clinical perspective on the magnitude of the change that Astym®
treatment may have on muscular strength we can use the following clinical example. A
patient with a musculoskeletal injury to the lower extremity may produce 1000 Newtons
of force during a maximal isometric squat test compared to 1200 Newtons on their noninvolved side. The maximal force produced during the squat test on the involved side
equates to squatting a maximum of 225 pounds. Following an Astym® treatment to the
lower extremity, we would expect the average maximal force output to increase by 15%.
For our clinical example, we would expect the patient to have an immediate improvement
of their maximal squat from 225 pounds to nearly 260 pounds or for an improvement of
35 pounds. This change in force output could temporarily enhance their ability to
perform their strengthening program, however, it remains unknown how long the effect
will last.
Multi-joint, lower extremity muscular strength has been shown to be directly
related to the functional abilities of an individual.21 Muscular strength measured with a
unilateral squat test has been associated with ambulatory and stair climbing function.22
Lower extremity muscular weakness is also a risk factor for falls in an elderly
population.23 In a younger, athletic population, lower extremity strength has been related
to sprinting speed as well as measures of agility and jumping ability.24,25,161 The
consensus of current scientific literature would suggest that multi-joint lower extremity
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strength has implications to a wide range of functional activities, from basic ambulatory
function to advanced athletic performance.
An area of future research would be to assess if the acute change in muscular
strength following Astym® treatment in fact enables patients to perform functional tasks
with less difficulty. This could include activities of daily living such as transitioning
from a seated to a standing position or climbing stairs. Astym® treatment may also be
used to help athletes with musculoskeletal injuries quickly improve their abilities to run,
change direction, or jump. Maximizing the effectiveness and efficiency of treatment
sessions in a physical therapy practice may be of elevated importance in today’s health
care environment where a physical therapist may be challenged to manage a patient’s
deficits in a limited number of visits. The results of the current study support the use of
Astym® treatment in the management of patients with a documented weakness from a
musculoskeletal injury/condition. The improvement in muscular strength produced by an
Astym® treatment may be seen best in individuals who have a diagnosis in which the
musculotendinous structures of the knee thigh region are injured. Based on the results of
the current study, conditions affecting non-contractile tissues or those involving the
structures of the foot, ankle, or leg may be less likely to experience an immediate
increase in muscle strength measured with a unilateral squat test. Therapists may choose
to use Astym® treatment as an efficient means to improve muscular strength, especially
among patients with lower extremity weakness caused by a musculotendinous injury to
the knee or thigh region.
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5.6 Limitations
There are limitations to the current study that deserve consideration when
interpreting the results. Limitations that challenge the cause and effect relationship
established between the independent variable (Astym® treatment) and the dependent
variable (percent change of maximal force output) are referred to as threats to the internal
validity of the study. This section will explore the limitations of the study that pose
potential threats to internal validity and how the threats were controlled. It will also
explore the potential threats to external validity. External validity refers to how the
results of the study can be generalized in other populations. The characteristics of the
subjects enrolled in the current study will be analyzed to determine the generalizability of
the reported effects of Astym® treatment on muscular strength.

5.6.1 Threats to Internal Validity
There are several potential threats to the internal validity of this study: selection
bias, testing effects, statistical regression, experimental mortality, instrumentation, and
design contamination. Each of these threats can affect the ability to establish a cause and
effect relationship between Astym® treatment and maximal force output.
5.6.1.1 Selection Bias
The most substantial threat to internal validity in a multi-group study design that
was employed in the current study is selection bias.162 A selection bias occurs when the
characteristics of the subjects in the groups that are being compared are inherently
different from each other.162 Thus the causality of the observed outcome cannot be
delineated from the inherent differences between the groups or the effect of the
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independent variable on the dependent variable. Random assignment of subjects to the
treatment groups was performed to minimize the likelihood of a selection bias. Statistical
comparisons of the treatment groups showed that none of the groups were statistically
different with regard to age, height, weight, lower extremity functional score, lowerextremity dominance, involved versus uninvolved strength deficit, or diagnosis.
Therefore, it was concluded that these subject characteristics likely did not contribute to
the main outcome of the study. The distribution of gender was not statistically different.
However, the Astym® treatment group had a greater female to male ratio (5:1), in
comparison to the control (3:1) and the placebo group (3:2). Although the males in the
Astym® treatment group proved to have a greater percent change in maximal force output
(20%) compared to the females (13%), the unequal distribution of males to females does
not allow an accurate statistical comparison to rule out the possibility of a gender bias
that could have influenced the results of the study.
5.6.1.2 Testing Effects
Testing effects are another consideration in a pre-test/post-test type of study design
that was used for this research project. Testing effects occur when the pre-test influences
the results of the post-test.162 Cumulative fatigue and learning effects due to the
familiarity of the testing procedures using the computerized leg press are two possible
testing effects to consider when interpreting the results of the current study. Pilot testing
that investigated the learning/fatigue effect during repeated testing on the computerized
leg press machine (Appendix C) was done prior to the initiation of the current study.
Based on this pilot data a familiarization protocol138 was adopted to control for
learning/fatigue effects for the computerized leg press machine.
85

The data from the control group as well as the data collected on the non-involved
side of the subjects enrolled in the study can be analyzed to assess the influence of testing
effects. The subjects that received the control condition had a -1 percent change of
maximal force output. Analysis of pre-test to post-test measures of the non-involved side
averaged a 4-6% decrease in percent change of maximal force output for each of the
designated treatment groups. The results of the pilot study as well as the analysis of data
collected for the control group and the non-involved sides of all the subjects demonstrates
strong evidence that testing effects did not impact the results of the current study. Thus
testing effects were not likely explanations for the improvement noted in maximal force
output of the subjects that received Astym® treatment.

5.6.1.3 Instrumentation Effects
Poor consistency and reliability of the instruments used to collect data is another
possible threat to internal validity.162 The computerized leg press machine used for this
study was calibrated to within 0.1 Newtons. Pilot data was collected prior to the
initiation of the current study to establish test-retest reliability and criterion validity of the
computerized leg press machine. (Appendix A and B). The computerized leg press
machine demonstrated excellent criterion validity (r=0.99) to a digital force
dynamometer. The test-retest reliability of the leg press machine was also excellent with
an ICC(2,1) of 0.99. Based on the pilot data, it is unlikely that an instrument effect
occurred to influence the results of the study.
An instrument effect may have also occurred as the investigator performed
treatment with the Astym® instruments. While the Astym® treatment protocol was
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standardized with regard to the order and the areas treated, the amount of pressure
applied during the treatment differed according to the thickness of the superficial fascia
overlying the muscular tissue. A lack of standardized treatment pressure may be
perceived as a weakness or confounding variable in the study. Using a predetermined
pressure, however, would presumably create a bias where leaner subjects would likely
receive greater mechanical stimulation of the soft-tissue compared to subjects with
greater mass or thicker adipose tissue over the muscle tissue. To account for the
variability of body composition among the subjects, the amount of pressure applied
during treatment was dependent on the appreciable change of tissue texture noted by the
investigator during the Astym® treatment. This allowed a consistent Astym® treatment
experience for each individual subject and is consistent with how Astym® treatment is
performed in clinical settings.

5.6.1.4 Regression to the Mean
A regression to the mean may occur when the subjects score extremely high or
extremely low on the measurement of interest. To be included in the current study,
subjects had to demonstrate a minimal deficit of 10% of maximal force output of their
involved side compared to the uninvolved side. Since subjects demonstrated a strength
deficit to qualify for the study, there could be concern that their scores would improve
regardless of treatment intervention with repeated testing. The average percent deficits of
the involved side to the non-involved side were 22%, 19%, and 20% for the Astym®,
placebo, and control treatment groups, respectively. The groups were not statistically
different for the average percent strength deficits, yet only the Astym® treatment group
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showed a positive improvement of maximal force output following treatment. Given that
the control and placebo groups did not improve maximal force output lessens the
likelihood that a regression towards the mean would explain the improvement observed
in the Astym® treatment group.

5.6.1.5 Design Contamination
Design contamination occurs when the subjects become aware of his/her
treatment group. This may motivate the subjects to apply more effort to meet the
expectations of the researchers. In the current study, subjects were blinded to their
assigned group. Only the primary investigator knew the treatment that was administered
to each subject. A second investigator performed all the testing and was blinded to the
treatment received by each subject. Blinding of the subject and the investigator
performing the testing can help to reduce the effects of design contamination. The
blinding methods used in the current study therefore minimize the threat of design
contamination.

5.6.1.6 History and Maturation Effects
An effect of history can occur when an event in the subject’s past influences their
outcome during the study. Similarly, maturation effects occur as the natural process of
growth and aging. History and maturation are potential threats that are more commonly
associated with longitudinal studies. The purpose of the current study was to examine the
acute effects of Astym® treatment on muscle strength, and thus the contracted time
between pre-test and post-test measures limits the effects of history or maturation on the
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results of the current study. However, if a subject had previously been exposed to
Astym® treatment, this could alter his/her perceptions of the treatment and lead to a
different result. For this reason, subjects with previous exposure to Astym® treatment
were excluded from participation in the study.

5.6.2 Threats to External Validity
External validity refers to the extent to which the results of the study are
generalizable to other populations. There are threats to the external validity of this study,
with regard to the type of the diagnoses as well as pre-existing weakness that may limit
the generalizability of the results of the current study. This section will explore the how
the type of diagnosis and pre-existing weakness may affect the generalizability of the
results to other populations of subjects.
The conclusions from this study should only be applied to adult patients with
muscular weakness caused by a musculoskeletal injury or condition affecting the lower
extremity. The sample of subjects from the current research study was recruited from an
outpatient physical therapy facility believed to be representative of a population
commonly seen in other outpatient physical therapy facilities. The diagnoses of the
subjects that participated in this research study were all musculoskeletal in nature. There
are other conditions that may cause muscular weakness including neuromuscular disease
or conditions that impair the central or peripheral nervous systems. None of the patients
in the study presented with weakness caused by a neuromuscular condition or disease
affecting the nervous system. Individuals with the aforementioned conditions may have
debilitating weakness that would benefit from therapeutic interventions to improve
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muscular performance. Although the results of the current study suggest a positive
influence of Astym® treatment on muscle strength among subjects with musculoskeletal
conditions, it remains unknown if weakness caused by neuromuscular disease or
impairments to the nervous system would experience a similar improvement of muscular
performance.
All of the subjects enrolled in the current study presented with a measurable
strength deficit of at least 10% when compared to the non-involved side. Those subjects
that did not have a minimum strength deficit of 10% were excluded. Therefore it remains
unknown how Astym® treatment may influence strength in those without a deficit.
Athletes are a population that may not present with weakness, but may benefit from an
increase in muscle performance. Anecdotal reports from athletes note enhanced athletic
performance immediately following Astym® treatment. However, no study has been
performed to test the influence of Astym® treatment on athletic performance. The results
of the current study are encouraging that Astym® treatment may facilitate athletic
performance by improving muscular strength, but the sample from this study included
only subjects that had muscular weakness and a known injury. Therefore, the results
cannot be generalized to an athletic population that is healthy or does not have an existing
strength deficit.

5.7 Future Research Considerations
The use of Astym® treatment in the management of musculoskeletal pathology is
relatively new and there remains limited evidence describing its effects on individuals
with various musculoskeletal conditions. The results of the current research project have
demonstrated how Astym® treatment acutely affects maximal force output during an
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isometric squat test. This discovery has generated interest in additional inquiries
examining the effects of Astym® treatment.
While Astym® treatment was shown to cause an acute change in muscle strength,
the longevity of this change remains unknown. Researchers have reported mechanical
stimulation in the form of brushing of the skin can cause excitatory changes in muscle
activity for up to 40 minutes after treatment.40,41 More current research has shown that
the mechanical stimulation produced with joint mobilization can influence muscular
strength for 15-30 minutes after treatment. Ghanbari et al.153 demonstrated that while
muscular strength of the knee extensors occurred immediately following a grade IV
mobilization of the knee joint, the maximal increase of muscular strength occurred 30
minutes after the joint mobilization. Makofsky et al.152 noted significant improvements in
hip abductor strength measures 15 minutes following grade IV inferior mobilization of
the hip joint. Grindstaff et al.163 studied the temporal effect of joint mobilization on
muscular strength. The results of the study by Grindstaff et al.163 showed a statistically
significant improvement in muscular strength and activation of the quadriceps muscle
group immediately following lumbopelvic manipulation, but the change was not
sustained upon repeated testing at 20, 40, and 60-minutes after the manipulation. Based
on these studies, one may speculate that the effect of Astym® treatment on muscular
strength would last 20-40 minutes, similar to the sustainability that has been previously
reported for joint mobilization and manipulation. A study that investigates the effect of
Astym® treatment on muscle strength over time is needed to determine the sustainability
of the effects of Astym® treatment on muscular strength.
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In addition to muscular strength, other aspects of muscle performance such as
muscular power may also be influenced by Astym® treatment. Power is defined as the
amount of energy output per unit of time and is often expressed as the amount of
muscular force multiplied by the velocity of movement.164 Muscular power is a strong
predictor of self-reported functional status 165 and predictive for falls in an elderly
population.166 Muscle power has also been associated with athletic performance in
cycling, 167 swimming, 168 jumping, 169 and sprinting 170 Current research indicates that
soft-tissue mobilization techniques such as massage and self-administered instrumentassisted techniques do not improve muscle power. McKechnie et al.80 demonstrated no
significant change in measures of muscle power following petrissage and tapotement
massage. Mikesky et al. 103 demonstrated no improvement of measures of muscle
performance after treatment using “the Stick”. Similarly, no change in muscle power
during a vertical jump was observed by Healey et al.118 after self-administered soft-tissue
mobilization with a foam roller. These studies, however, also demonstrated no effect on
muscular strength, which is contradictory to the findings from this current research
project. Whether Astym® treatment would cause an increase of muscular power that is
similar to the increase that was demonstrated for muscular strength is unknown. There is
a need for studies that examine the effects of Astym® treatment on muscular power and
the implications to functional activities, athletic performance, and injury prevention.
Another potential research inquiry may be to investigate how Astym® treatment
can directly influence function. The ability to perform activities of daily living such as
walking and negotiating stairs have been related to measures of muscular strength.118
Muscular strength has also been related to athletic performance in measures such as
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timed sprinting speed and vertical jump height.24,25,161 Since the results of the current
research project demonstrated improvements in strength, it may be hypothesized that
functional performance measures may also demonstrate acute improvements. Previous
research has shown that Astym® treatment can help to improve measures of self-reported
function.1,4,7,11,17 However, these studies were primarily case series or studies and
examined the impact of Astym® treatment over the course of several treatments. As a
result, there remains little quality and quantity of evidence to establish a cause and effect
relationship between Astym® treatment and measures of functional performance. Future
research may investigate the effect of Astym® treatment on functional performance tests
through clinically controlled trials. Examples of functional performance tests may
include the stair climb test, that measures the time it takes a patient to ascend and descend
a flight of stairs, or the timed-up-and-go test that measures the ability to transition from
sit-to-stand and walk.171 Functional performance in an athletic population may be
measured by agility and balance tests, timed run tests, and hop/jump tests.172 Future
research that examines the impact of Astym® treatment on measures of functional
performance, specifically on the abilities of individuals to perform common daily or
athletic activities may help to determine the clinical significance of the acute changes in
muscular strength observed in the current research project.
Future research may also investigate the mechanisms such as pain modulation,
neuromuscular facilitation, mechanosensitivity of muscle tissue, and increased blood
flow, through which Astym® treatment is hypothesized to influence muscular strength.
Previous studies have investigated the effects of therapeutic interventions on acute
muscle pain and weakness caused by an aggressive eccentric exercise protocol.173-175
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Eccentric exercise protocols can create delayed onset muscle soreness and cause
temporary damage to muscle tissue that coincides with a loss of muscular strength.173-175
A research project that induces delayed onset muscle soreness and then evaluates the
effect of Astym® treatment to reduce the associated pain and restore muscular strength
deficits may help to determine the association of pain reduction and muscle performance.
Such a study may also determine if Astym® treatment is indicated to manage delayed
onset muscle soreness. Pain can also be produced in laboratory settings with a hypotonic
injection into a joint.66,71,73,175-177 Muscle strength measures have been shown to
significantly decrease following an injection of hypotonic solution into an otherwise
healthy joint. 66,71,73,175-177 A research project that examines the effect of Astym® treatment
on muscle strength after laboratory induced joint pain may help to explain if improved
muscle performance is related to reduction of pain and may further determine the role of
Astym® treatment for patients with impaired muscular strength caused by joint pain.
To determine the effect of Astym® treatment on the sensorimotor system, a
clinical trial may be constructed that uses an anesthetic nerve block that impedes sensory
input to the brain, but does not affect motor signals to working muscles. The current
study used a placebo intervention that consisted of tactile stimulation using lighter
pressure to avoid contact with the deeper, musculoskeletal tissue. The placebo group
received sensory stimulation from the mechanoreceptors found in the skin but differed
from the Astym® treatment group in that there was careful attention not to stimulate the
musculotendinous and fascial structures deep to the skin. The results showed a
statistically significant increase of muscular strength for the Astym® treatment group, but
not the placebo group. This could suggest that tactile stimulation of the skin does not
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play a major role in the acute changes in muscular strength that were observed in this
study, but perhaps stimulation of the mechanoreceptors in the musculotendinous and
fascial structures are important to inducing a change in muscular strength. There is
conflicting evidence regarding the influence of tactile stimulation and muscle
performance. Tactile stimulation of the skin while wearing a neoprene sleeve was a
proposed mechanism explaining improved measures of muscle performance according to
research performed by Call.178 Similarly, studies have shown that use of elastic 179,180 and
non-elastic taping techniques 181-183 increases muscle activation and performance. Other
studies, however, have shown no influence of taping techniques on muscle
performance.184-189 A recent meta-analysis of the evidence of elastic taping on muscle
performance showed inconsistent findings and reached no definitive consensus on the
effect of various taping techniques on muscle performance.190 Therefore, it remains
uncertain what effect tactile stimulation to the skin may have on measures of muscle
performance. A research project that compares the impact of Astym® treatment on
muscle strength in conditions with sensory input blocked versus conditions with the
sensory system in tact may help to further determine if stimulation of the sensorimotor
system from Astym® treatment could explain the acute changes in muscular strength
observed in the current research study.
Determining how mechanical stimulation influences calcium concentrations in
muscle tissue may further help to explain the mechanisms through which Astym®
treatment influences muscular strength. However, measures of intra-cellular calcium are
difficult to attain in vivo and require advanced laboratory techniques to measure.191
Laboratory studies using animal models may compare intra-muscular calcium
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concentrations of muscle tissue treated with Astym® to muscle tissue not treated with
Astym®. Ziman et al.191 described novel methods to measure concentrations of calcium
released by the sarcoplasmic reticulum, however, these methods have not been used on
human tissue. To determine the effect of Astym® treatment on calcium exchange in
muscle tissue, animal studies using advanced methodology would be necessary until
novel measures can be developed that can quantify calcium exchange occurring in human
muscle in vivo.
The effect of Astym® treatment on blood flow may be another potential research
question. Previous research has demonstrated that soft-tissue mobilization in the form of
massage increases local blood flow to treated areas. 93,95,149 Massage has also shown to
increase muscle temperature.99 While it would be reasonable to suggest that Astym®
treatment may induce similar increases in blood flow and tissue temperature, no study to
date has been performed to investigate the effect of Astym® treatment on local blood flow
and tissue temperature. Such studies would provide evidence that would help determine if
increases of blood flow and tissue temperature accompany improvements in muscular
strength.
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5.8 Conclusions
1. Astym® treatment caused an acute improvement on maximal force output during a
unilateral isometric squat test. Subjects that received Astym® treatment had a
significantly greater percent change in pre-treatment to post-treatment maximal force
output than the subjects that received no treatment (control) and the subjects that
received a sham Astym® treatment (placebo).
2.

Subjects that received the control and placebo treatment did not yield an acute
improvement in maximal force output during a unilateral isometric squat test.

3.

Future research is needed to understand the physiologic mechanisms that explain
how Astym® treatment increases muscular strength, the longevity of the observed
increases in muscular strength, and to determine if Astym® treatment will also result
in acute changes in muscle power, functional abilities, and athletic performance.
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APPENDIX A. VALIDITY OF COMPUTERIZED LEG PRESS MACHINE

To establish evidence of validity, a pilot study was performed to determine the
agreement of the maximum force output recorded with a digital force dynamometer
(criterion) versus the computerized leg press machine (practical test) during a maximal
isometric squat test. A digital force dynamometer (Microfet 2 Manual Muscle Testing
Handheld Dynamometer; Salt Lake City; Utah) that was calibrated to within one
hundredth of a Newton was secured to the surface of the foot plate of the computerized
leg press machine. The subject then placed their foot on the center of the dynamometer
and was asked to push through their foot as hard as possible. The agreement of the force
computed on the computerized leg press machine to the dynamometer was determined for
21 consecutive trials using a Pearson correlation coefficient. The computerized leg press
machine demonstrated evidence of excellent criterion validity to the digital force
dynamometer with a Pearson correlation coefficient of 0.99. The Typical Error of the
Estimate was also computed through linear regression.192 The Typical Error of the
Estimate represents the typical amount by which the estimate is wrong for any given
subject. The analysis revealed the Typical Error of the Estimate to be 10.69 Newtons
(95% CI: 8.13-15.62 Newtons).
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APPENDIX B. RELIABILITY OF THE COMPUTERIZED LEG PRESS MACHINE
A pilot study was performed to establish test-retest reliability of the Computerized
Leg Press Machine. Twelve subjects healthy performed 3 repetitions of maximal
isometric testing on the computerized leg press machine. After a 12 minute rest, maximal
isometric testing on the computerized leg press machine was repeated with an additional
3 repetitions. An intra-class correlation coefficient (ICC) was computed from the average
of the first 3 repetitions and the average of the final 3 repetitions of maximal isometric
testing. Test-retest reliability of maximal isometric testing using the computerized leg
press machine was determined with an ICC(2,1) of 0.99. The standard error of the
measurement is a reliability measure that estimates the given error in a set of measures.
The standard error of the measurement was determined to be a 2.7 %change in maximal
force output. The minimal detectable change represents the smallest amount of change in
a given measure that is not attributable to measurement error. The minimal detectable
change is computed as a confidence interval of the standard error of the measurement.
Using a 95% confidence interval, the minimal detectable change was determined to be
7.5 %change in maximal force output.
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APPENDIX C. ANALYSIS OF LEARNING AND FATIGUE EFFECT
A repeated measures analysis of variance was performed to determine if trial
number influenced the subject’s test performance on an isometric squat test. Determining
a learning effect or fatigue effect is important in establishing a testing protocol that best
represents the subject’s true performance. A learning effect would be represented by an
improvement of test performance with repeated trials. A fatigue effect would be
represented by a decline in test performance with repeated trials. Fourteen healthy
subjects performed 10 repeated trials of isometric testing on a computerized leg press
machine. The results indicated a significant effect of trial number to isometric force
output (F(9,5) = 5.27, p<0.05). Analysis of a plot of the estimated marginal means
(Figure 9) shows a learning effect that occurs between trial 1 and 2. On average this
accounted for approximately a 5% increase between trial 1 and 2. After trial 2, there
appears to be a gradual linear decline in performance indicating the possibility of fatigue
until trial 9. The average decline in performance between trial 2 and trial 9 is
approximately 6%. The pairwise comparisons between trials, however, did not
demonstrate a significant difference between any of the 10 trials. Although pairwise
comparisons of trial 1 and trial 2, and trial 2 and trial 9 did not reach statistical
significance, the testing protocol should account for the tendency of an initial learning
effect and the possibility of a gradual fatigue effect with repeated testing. Carcia et al. 138
described a familiarization protocol for unilateral isometric testing on a computerized leg
press machine. Based on data from our pilot study, the familiarization protocol described
by Carcia et al. 138 would account for an initial learning effect and limit fatigue by
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averaging only three trials performed at maximal effort. For this reason, the
familiarization protocol described by Carcia et al.138 was adopted for the proposed
research study.

Figure 9. Estimated Marginal Means of the Trial Number
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Appendix D. The frequency of gender, lower extremity dominance, and diagnosis of the
subjects according to treatment group.
Subject
Number

Gender

Lower Extremity
Dominance

Diagnosis

1

F

R

2

F

R

4

F

L

8
9
15

M
M
F

R
R
R

17

F

R

21
24
25

F
M
F

R
R
R

27

F

R

33
40
44
45

F
F
F
F

R
R
R
R

HAMSTRING STRAIN
TROCHANTERIC
BURSITIS
ACHILLES
TENDINOPATHY
DISTAL ITB FRICTION
SYNDROME
HAMSTRING STRAIN
PATELLOFEMORAL PAIN
DISTAL ITB FRICTION
SYNDROME
FEMOROACETABULAR
IMPINGEMENT
PLANTAR FASCIITIS
LABRAL TEAR
TIBIALIS POSTERIOR
TENDINOPATHY
DISTAL ITB FRICTION
SYNDROME
PATELLOFEMORAL PAIN
PLANTAR FASCIITIS
MENISCAL TEAR

3
5
7
13
14
20
22
26
29
30
34
38
41

F
F
M
F
F
M
M
M
F
F
M
F
F

R
R
R
L
R
R
R
R
R
R
R
R
R

POSTERIOR TIBIALIS
TENDINOPATHY
MCL SPRAIN
ADDUCTOR STRAIN
ANKLE SPRAIN
PATELLOFEMORAL PAIN
PATELLOFEMORAL PAIN
PLANTAR FASCIITIS
PATELLOFEMORAL PAIN
ANKLE SPRAIN
KNEE OSTEOARTHRITIS
PLICA
HAMSTRING
PATELLOFEMORAL

Astym

Control
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42

F

R

43

F

R

6

F

R

10
11
12
16
18
19
23
28
31
32
35
36
37
39
6

M
F
F
M
F
F
F
M
M
F
M
F
F
M
F

R
R
R
R
R
R
R
R
L
R
L
R
R
R
R

PAIN/QUAD STRAIN
FEMOROACETABULAR
IMPINGEMENT
POSTERIOR TIBIALIS
TENDINOPATHY

Placebo
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MCL SPRAIN
PATELLAR
DISLOCATION
PATELLOFEMORAL PAIN
SHIN SPLINTS
PLANTAR FASCIITIS
PES ANSERINE BURSITIS
PATELLOFEMORAL PAIN
QUAD STRAIN
HAMSTRING
HAMSTRING
QUAD STRAIN
HAMSTRING
PATELLOFEMORAL PAIN
MENISCAL TEAR
PLANTAR FASCIITIS
MCL SPRAIN

Appendix E. Raw Data
Sub#

Group

Age

Ht

Wt

LEFS

%
Deficit

PrePain

PostPain

PostTest
(N)
1308

%Diff

1

Pretest
(N)
1082

1

A

53

165

60

50

23

5

2

A

45

172

68

68

19

3

0

658

864

31

3

C

49

155

51

65

30

2

2

607

753

29

4

A

28

170

70

70

11

0

0

1191

1543

29

5

C

58

165

73

66

11
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A= Astym treatment group; B= Placebo treatment group; C= Control group:
LEFS= Lower Extremity Functional Score.
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